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A B S T R A C T
Background
Differentiating both typhoid (Salmonella Typhi) and paratyphoid (Salmonella Paratyphi A) infection from other causes of fever in
endemic areas is a diagnostic challenge. Although commercial point-of-care rapid diagnostic tests (RDTs) for enteric fever are available
as alternatives to the current reference standard test of blood or bone marrow culture, or to the widely usedWidal Test, their diagnostic
accuracy is unclear. If accurate, they could potentially replace blood culture as the World Health Organization (WHO)-recommended
main diagnostic test for enteric fever.
Objectives
To assess the diagnostic accuracy of commercially available rapid diagnostic tests (RDTs) and prototypes for detecting Salmonella Typhi
or Paratyphi A infection in symptomatic persons living in endemic areas.
Search methods
We searched the Cochrane Infectious Diseases Group Specialized Register, MEDLINE, Embase, Science Citation Index, IndMED,
African Index Medicus, LILACS, ClinicalTrials.gov, and theWorld Health Organization (WHO) International Clinical Trials Registry
Platform (ICTRP) up to 4March 2016. Wemanually searchedWHO reports, and papers from international conferences on Salmonella
infections. We also contacted test manufacturers to identify studies.
Selection criteria
We included diagnostic accuracy studies of enteric fever RDTs in patients with fever or with symptoms suggestive of enteric fever living
in endemic areas. We classified the reference standard used as either Grade 1 (result from a blood culture and a bone marrow culture)
or Grade 2 (result from blood culture and blood polymerase chain reaction, or from blood culture alone).
Data collection and analysis
Two review authors independently extracted the test result data. We used a modified QUADAS-2 extraction form to assess method-
ological quality. We performed a meta-analysis when there were sufficient studies for the test and heterogeneity was reasonable.
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Main results
Thirty-seven studies met the inclusion criteria and included a total of 5080 participants (range 50 to 1732). Enteric fever prevalence
rates in the study populations ranged from 1% to 75% (median prevalence 24%, interquartile range (IQR) 11% to 46%). The included
studies evaluated 16 different RDTs, and 16 studies compared two or more different RDTs. Only three studies used the Grade 1
reference standard, and only 11 studies recruited unselected febrile patients. Most included studies were from Asia, with five studies
from sub-Saharan Africa. All of the RDTs were designed to detect S.Typhi infection only.
Most studies evaluated three RDTs and their variants: TUBEX in 14 studies; Typhidot (Typhidot, Typhidot-M, and TyphiRapid-
Tr02) in 22 studies; and the Test-It Typhoid immunochromatographic lateral flow assay, and its earlier prototypes (dipstick, latex
agglutination) developed by the Royal Tropical Institute, Amsterdam (KIT) in nine studies. Meta-analyses showed an average sensitivity
of 78% (95% confidence interval (CI) 71% to 85%) and specificity of 87% (95% CI 82% to 91%) for TUBEX; and an average
sensitivity of 69% (95% CI 59% to 78%) and specificity of 90% (95% CI 78% to 93%) for all Test-It Typhoid and prototype tests
(KIT). Across all forms of the Typhidot test, the average sensitivity was 84% (95% CI 73% to 91%) and specificity was 79% (95%
CI 70% to 87%). When we based the analysis on the 13 studies of the Typhidot test that either reported indeterminate test results or
where the test format means there are no indeterminate results, the average sensitivity was 78% (95% CI 65% to 87%) and specificity
was 77% (95% CI 66% to 86%). We did not identify any difference in either sensitivity or specificity between TUBEX, Typhidot,
and Test-it Typhoid tests when based on comparison to the 13 Typhidot studies where indeterminate results are either reported or not
applicable. If TUBEX and Test-it Typhoid are compared to all Typhidot studies, the sensitivity of Typhidot was higher than Test-it
Typhoid (15% (95% CI 2% to 28%), but other comparisons did not show a difference at the 95% level of CIs.
In a hypothetical cohort of 1000 patients presenting with fever where 30% (300 patients) have enteric fever, on average Typhidot tests
reporting indeterminate results or where tests do not produce indeterminate results will miss the diagnosis in 66 patients with enteric
fever, TUBEX will miss 66, and Test-It Typhoid and prototype (KIT) tests will miss 93. In the 700 people without enteric fever, the
number of people incorrectly diagnosed with enteric fever would be 161 with Typhidot tests, 91 with TUBEX, and 70 with Test-
It Typhoid and prototype (KIT) tests. The CIs around these estimates were wide, with no difference in false positive results shown
between tests.
The quality of the data for each study was evaluated using a standardized checklist called QUADAS-2. Overall, the certainty of the
evidence in the studies that evaluated enteric fever RDTs was low.
Authors’ conclusions
In 37 studies that evaluated the diagnostic accuracy of RDTs for enteric fever, few studies were at a low risk of bias. The three main
RDT tests and variants had moderate diagnostic accuracy. There was no evidence of a difference between the average sensitivity and
specificity of the three main RDT tests. More robust evaluations of alternative RDTs for enteric fever are needed.
P L A I N L A N G U A G E S U M M A R Y
The accuracy of rapid diagnostic tests for detecting typhoid and paratyphoid (enteric) fever
Cochrane researchers assessed the accuracy of commercially-available rapid diagnostic tests and their prototypes (including TUBEX,
Typhidot, Typhidot-M, Test-it Typhoid, and other tests) for detecting typhoid and paratyphoid (enteric) fever in people living in
countries where the estimated number of individuals with the disease at any one time is greater than 10 per 100,000 population.
If accurate, they could replace the current World Health Organization (WHO)-recommended diagnostic test: culture (growing the
bacteria that causes the infection from a patient’s blood or bone marrow).
Background
Typhoid fever and paratyphoid fever are infections caused by the bacteria Salmonella Typhi and Salmonella Paratyphi A respectively.
The term ‘enteric fever’ is used to describe both infections. Enteric fever can be difficult to diagnose as the signs and symptoms are
similar to those of other infectious diseases that cause fever such as malaria.
The recommended test to confirm if a person has enteric fever is to grow the Salmonella from their blood. It takes at least 48 hours to
give a result, so cannot help healthcare workers make a diagnosis the same day the blood culture is taken. Blood cultures may give a
negative result even though a person has enteric fever. The test also requires a laboratory and trained staff, which are often unavailable
in communities where enteric fever is common.
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Rapid diagnostic tests (RDTs) are designed to be easy to use, and to deliver a quick result without the need for a blood culture laboratory.
The cost of an enteric fever RDT would be significantly less than a blood culture, and requires less training to perform.
Study characteristics
Cochrane researchers searched the available literature up to 4 March 2016 and included 37 studies. Most studies recruited participants
from South Asia. Most participants were adults, with 22 studies including children. All of the RDTs evaluated detected Salmonella
Typhi (typhoid fever) only.
Quality of the evidence
The Cochrane researchers evaluated the quality of the data for each study using a standardized checklist called QUADAS-2. High
quality studies that compared different types of RDT in the same patients were few in number. Two-thirds of the included studies did
not evaluate the RDTs in the context of patients who are typically tested for the disease. Many studies utilized a particular study design
(a case control study) which risks overestimating RDT accuracy. In the studies evaluating the Typhidot RDT, it was often unclear how
many test results were indeterminate, when the test cannot distinguish a current episode of infection from a previous disease episode.
Overall, the certainty of the evidence in the studies that evaluated enteric fever RDTs was low.
Key results
Sensitivity indicates the percentage of patients with a positive test result who are correctly diagnosed with disease. Specificity indicates
the percentage of patients who are correctly identified as not having disease. TUBEX showed an average sensitivity of 78% and specificity
of 87%. Typhidot studies, grouped together to include Typhidot, Typhidot-M, and TyphiRapid-Tr02, showed an average sensitivity of
84% and specificity of 79%. When Typhidot studies with clear reporting of indeterminate results are considered, the average sensitivity
and specificity of Typhidot was 78% and 77% respectively. Test-It Typhoid and prototypes (KIT) showed an average sensitivity of 69%
and specificity of 90%.
Based on these results, in 1000 patients with fever where 30% (300 patients) have enteric fever, we would expect Typhidot tests reporting
indeterminate results or where tests do not produce indeterminate results to, on average, miss the diagnosis (give a false negative result)
in 66 patients with enteric fever, TUBEX to miss 66, and Test-It Typhoid and prototypes (KIT) to miss 93. In the 700 people without
enteric fever, the number of people incorrectly given a diagnosis of enteric fever (a false positive result) would be on average 161 with
these Typhidot tests, 91 with TUBEX, and 70 with the Test-It Typhoid and prototypes (KIT). These differences in the number of
false negative and false positive results in patients from the different tests are not statistically important. The RDTs evaluated are not
sufficiently accurate to replace blood culture as a diagnostic test for enteric fever.
B A C K G R O U N D
Target condition being diagnosed
Typhoid and paratyphoid (enteric) fever are diseases caused by
Salmonella enterica serovar Typhi and Paratyphi A respectively. Ty-
phoid, the more common infection, is an important infectious
disease in low- and middle-income countries (LMICs) with over
22 million new cases worldwide and an estimated 200,000 deaths
annually (WHO 2003). South and South-East Asia are the most
affected areas of the world, with an estimated annual incidence
in some areas of greater than 100 people per 100,000 population
(Crump 2004). Enteric fever is common in areas with inadequate
sanitation and hygiene, particularly regarding food, water, and dis-
posal of human excrement, andonly to this extent are these diseases
tropical (Gill 2009). Despite advances in technology and public
health strategies, enteric fever remains a major cause of morbid-
ity in the developing world (Bhutta 2006). Urbanization, global
warming, and traditional methods of waterside living have cre-
ated even greater demands for clean water in developing countries
(UNICEF 2006). We will use the term ’enteric fever’ throughout
this Cochrane Review to include both typhoid and paratyphoid
fever, unless specified. The causative organisms are Gram-negative
bacilli that are transmitted by the faecal-oral route when a person
ingests food or water that is contaminated with infected human
faeces. The most important reservoirs of infection are short-term
convalescents or chronic human carriers. Food handlers who are
carriers are a particularly important source of transmission (Gill
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2009; Andrews 2015).
The clinical presentation of enteric fever varies from a mild illness
with a low-grade fever, malaise, and slight dry cough to a severe
clinical illness with multiple complications including intestinal
perforation (Ismail 2006). Toxic apathy, blanching ’rose spots’ on
the trunk, abdominal organomegaly, and diarrhoea are also asso-
ciated with enteric fever, but the clinical picture is highly variable
between geographical location and age groups. Enteric fever can
present in many different and non-specific ways, thus posing a
diagnostic challenge for the health professional. Enteric fever is
usually diagnosed on clinical grounds and treated presumptively.
The diagnosis may be delayed or missed, while other febrile ill-
nesses are being considered (Parry 2002).
There is antimicrobial resistance to S. enterica serovar Typhi and
Paratyphi Aworldwide (Kariuki 2015).Health professionals in the
tropics overprescribe antimicrobials for many reasons, including
cultural factors and patient expectation (Okeke 2005). The pur-
chase of drugs such as antimicrobials from untrained vendors and
unlicensed pharmacists is commonplace in the developing world
(Larsson 2008). A major challenge is the inability to confirm di-
agnoses in resource-limited settings where traditional laboratory
methods of diagnosing enteric fever are unavailable. Healthcare
workers are therefore reliant on their clinical skills to make an ed-
ucated guess of the cause of illness or to prescribe an antimicrobial
that targets several bacteria, or both (Shetty 2008). This over treat-
ment has contributed to increasing resistance to fluoroquinolones
(for example, ciprofloxacin) and multiple drug resistance (resis-
tance to chloramphenicol, ampicillin, and co-trimoxazole) in S.
enterica serovar Typhi and Paratyphi A in endemic Asian countries
(Chuang 2009).
Index test(s)
Current enteric fever rapid diagnostic tests (RDTs) include a va-
riety of different methods and formats. RDTs can be applied to
blood or urine samples, with blood RDTs (using either venous or
capillary samples, or both) most common. Test formats are based
on lateral flow, flow-through, agglutination, or solid phase meth-
ods (Pastoor 2008). RDTs may detect antigens (components of
the causative Salmonella organism) or antibodies (markers of the
person’s immune response to the antigen). The type of antibody
class or immunoglobulin detected could be either immunoglob-
ulin-M (IgM), which may be indicative of recent exposure, or
immunoglobulin-G (IgG), which can indicate recent or previous
exposure. Examples of commercial RDTs for enteric fever that
have been undergoing evaluation in recent years include Typhidot
®, Typhidot-M®, and TUBEXT M (Baker 2010; Thriemer 2013).
Future RDTs are also likely to take a serological approach, al-
though the identification of novel antigens that are free of cross-
reacting epitopes is a major challenge (Baker 2010).
Typhidot, TUBEX, and Test-It Typhoid (KIT) RDTs
The three commercially available index tests that have most com-
monly been evaluated in published studies are: Typhidot (includ-
ing Typhidot-M, and TyphiRapid Tr-02); TUBEX; and Test-It
Typhoid and its earlier prototypes developed by the Royal Tropi-
cal Institute (KIT), Amsterdam. The Typhidot test measures both
IgM and IgG antibodies against a 50 kDa outer membrane pro-
tein (OMP) antigen in a miniaturized dot-blot enzyme-linked im-
munosorbent assay (ELISA) format. The test is considered posi-
tive if the IgM is positive, and indeterminate if the IgG is positive
but IgM negative. The Typhidot-M test measures IgM against the
same 50 kDa antigen in the same dot-blot format after removal
of the total IgG. The TyphiRapid Tr-02 test measures IgM anti-
bodies against the 50 kD antigen in an immunochromatographic
(ICT) format.
The TUBEX TF tests for antibodies against S. Typhi lipopolysac-
charide (LPS) antigen by quantifying inhibition of binding be-
tween O9monoclonal antibodies and LPS-coupled magnetic par-
ticles. A visible decolourization of patient serum in the test reagent
solution through magnetic particle separation indicates a positive
result. Samples are graded as 0 to 10 according to the colour of
the reaction mixture at the end of the procedure. Those with a
grade greater than 2 are considered positive. Unlike the Typhidot
test there has been a single version of the TUBEX test, although
there may have been minor test modifications not made public by
the manufacturer (Thriemer 2013).
The tests developed by KIT detect IgM antibodies against the S.
Typhi LPS O9 antigen. The test has been applied in different for-
mats as a prototype RDT using a dipstick and latex agglutination
format, and an ICT lateral flow assay. The ICT lateral flow format
is now commercially available as the Test-it Typhoid test.
Other RDTs included
Enterocheck WB® detects S. Typhi-specific antibodies to LPS
antigen in an ICT lateral flow format. As the patient sample flows
through the cassette, the antibody-antigen complexes are immo-
bilized by a coated membrane leading to the formation of a pink
to pink-purple coloured band. The absence of this coloured band
in the test region indicates a negative test result (Anusha 2011;
Anagha 2012).
SD Bioline similarly utilizes an ICT method to visually and qual-
itatively detect IgG and IgM antibodies to unspecified S. Typhi
antigens which are indirectly labelled with colloidal gold (via an
antibody). The immune complexes are captured by anti-IgM or
anti-IgG antibodies immobilized on the test strip to give a quali-
tatively positive or negative result (Kawano 2007).
The Multi-Test Dip-S-Tick is also a qualitative test, but in a dip-
stick format that detects IgG antibodies against S. Typhi O, H,
and Vi antigens. It is part of a fever stick which tests for five other
pathogens in addition to S. Typhi (Olsen 2004).
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The PanBio test utilizes a direct ELISA format. Unspecified S. Ty-
phi antigen-coated microwell strips are incubated with a patient’s
serum for 20 minutes. The absorbance readings at a wavelength
of 450 nm are converted into ’PanBio units’ with greater than 10
PanBio units considered positive, and less than 10 PanBio units as
negative (Gopalakrishnan 2002).
With theMega Salmonella test, patient antibodies bind to unspec-
ified S. Typhi antigens insolubilized on microplates, and are quan-
titatively detected by ELISA with both an IgM and IgG-specific
peroxidase-labelled reagent (Kawano 2007).
Clinical pathway
Prior test(s)
A RDT for enteric fever should be used in a patient who presents
with fever who currently lives in, or has recently visited, an area
of medium to high endemicity. It is likely that patients would not
have received any prior testing. However, it is more likely that a
patient may have been given a clinical diagnosis, or indeed em-
pirical antimicrobial treatment, based on history and examination
(Darton 2014). The setting could be primary, secondary, or even
tertiary care, but more commonly in a setting that has limited di-
agnostic laboratory facilities. Unfortunately the clinical diagnosis
of the disease is imprecise, so any patient with a fever from en-
demic regions should be subject to an enteric fever RDT, not just
those with classical signs and symptoms of the target conditions
(Parry 2011). In areas endemic for HIV, dengue, and malaria as
well as enteric fever, patients may have had other point-of-care
testing performed (Abba 2011).
Role of index test(s)
The definitive diagnosis of enteric fever requires confirmationwith
a laboratory test to distinguish it from other infections (such as
dengue,malaria, rickettsial infections, leptospirosis, andmelioido-
sis) that present with similar symptoms (Waddington 2014). The
current recommendation is to use blood culture to diagnose en-
teric fever (WHO 2003). This test is specific, but lacks sensitivity
and so will miss patients who actually have the disease (Mogasale
2016). A bone marrow culture, althoughmore sensitive, is imprac-
tical for routine use (Wain 2001). Furthermore, bacterial culture
requires a relatively sophisticated laboratory usually unavailable in
areas where enteric fever is common (Parry 2011).
It is anticipated that in low-resource settings endemic for enteric
fever, a robust RDT could be utilized instead of blood or bone
marrow cultures in a febrile patient, that is to replace the expensive
reference standard test in daily clinical practice. A positive RDT
result at the point-of-care would prompt treatment with appropri-
ate antimicrobials. A negative result would prompt consideration
of other illnesses as the cause of the patient’s fever (Parry 2011).
Simple, accurate, and robust RDTs would be of considerable help
to clinicians managing patients in areas where enteric fever is com-
mon (Baker 2010). In addition, an enteric fever RDT could be
used as a triage tool to trigger further testing, such as blood cul-
ture, in settings where microbiological culture is less accessible. In
secondary or tertiary care settings a positive RDT could warrant
the collection of a peripheral blood culture prior to starting an-
timicrobial therapy (Parry 2011).
Alternative test(s)
Widal test
TheWidal test (WT) is a serological test that detects agglutinating
antibodies to LPS (O antigen) and flagella (H antigen). The WT
is the principal alternative test and is widely used but is neither
sensitive nor specific (Olopoenia 2000). In its original format the
WT required both acute and convalescent-phase serum samples
taken approximately 10days apart. The test has also been evaluated
as a single, acute-phase serum sample (Saha 1996). In people with
enteric fever, titres often rise before the clinical onset, making it
very difficult to demonstrate the diagnostic four-fold rise between
initial and subsequent samples (Gill 2009).
The role of the WT is controversial because the sensitivity, speci-
ficity, and predictive values vary considerably between geographi-
cal areas (Parry 2002). Test results need to be interpreted carefully
in the light of previous history of enteric fever and vaccination.
Interpretation of the result is also greatly helped by knowledge of
the background levels of antibodies in the local healthy population
(House 2001). The increasing use of enteric fever vaccines and
the occurrence of infection with other Salmonella enterica serovars
lower the specificity of theWT(Waddington2014). Infectionwith
non-Salmonella organisms (for example, malaria, dengue, brucel-
losis) also leads to cross-reactivity in the WT in enteric fever-en-
demic regions (Olopoenia 2000). There is considerable variation
in agglutinin levels among non-infected populations. These levels
are susceptible to change over time and depend on the degree of
endemicity (Parry 2002). Despite these shortcomings of both sen-
sitivity and specificity, because the WT is simple and inexpensive,
it is still widely used as a diagnostic test (Fadeel 2004).
Nucleic acid amplification tests
Nucleic acid amplification tests (NAATs) for enteric fever diagno-
sis, such as polymerase chain reaction (PCR), and real-time PCR
are being explored. Theoretically, NAATs could amplify DNA
from dead or unculturable bacteria, thus addressing the concern
of poor culture positivity because of pre-treatment with antimi-
crobials (Wain 2001). One study found that a novel three-colour
real-time PCR technique had the same limitations in test sensi-
tivity as culture and deemed it an unsuitable methodology for the
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routine diagnosis of enteric fever (Nga 2010). Methods that com-
bine culture and PCR methods have been also been tested (Zhou
2010). The use of NAATs in developing countries will most likely
be limited in the medium-term because of high cost and the lack
of laboratory infrastructure (Olsen 2004).
Metabolomics
A new group of diagnostic tests rely on the metabolites produced
by the host in response to infection. Metabolites induced by spe-
cific infections could be measured in the blood and urine of af-
fected patients (Baker 2010). By comparing the metabolite pro-
files from healthy patients to profiles of patients with typhoid and
paratyphoid infections, thresholds could be determined to identify
those with acute enteric fever (McKinnon 2014). Similar studies
have used metabolomics to identify diagnostic markers of malaria
and dengue fever (Andrews 2015). The use of metabolomic tests
currently requires specialized laboratory infrastructure, so use of
these tests in both developed and developing countries is likely to
have very restricted applicability.
Rationale
RDTs have the potential to be useful to clinicians working in re-
source-limited settings in LMICs. Differentiating the common
causes of the febrile patient by clinical criteria is challenging with-
out the laboratory support for blood films, serology, or blood cul-
tures (Bhutta 2006). A diagnostic test in such a setting must be
cheap, simple to perform, and able to quickly deliver a result.
Such a test should correctly identify true enteric fever cases among
febrile patients, ensuring prompt and specific treatment, allowing
the avoidance of broad-spectrum medication that cover all com-
mon causes of fever. In many endemic areas, treatment for en-
teric fever may be given to all patients with fever (Larsson 2008).
The diagnosis of enteric fever by an RDT could reduce unneces-
sary prescription of antimicrobials, reduce drug expenditure, and
limit the development of antimicrobial resistance (Andrews 2015).
The role of an enteric fever RDT in practice is to identify those
febrile patients who warrant anti-Salmonella antibiotic treatment
as opposed to conservative management, antimalarial treatment,
or treatment for other bacterial infections (Parry 2011).
The reference standard for diagnosing enteric fever has been cul-
ture of S. Typhi or Paratyphi A from bone marrow, peripheral
blood, or other sterile sites. The mainstay of diagnosis in clini-
cal practice is a positive blood culture, although the test is only
positive in 40% to 80% of cases, usually in the first two weeks
of the disease (Parry 2002; WHO 2003). This lack of sensitiv-
ity is due to the low number of bacteria circulating in the blood,
and may also be affected by: prior antimicrobial therapy (Wain
1998); the type of culture medium used; the ratio of blood to
broth; stage of illness at the time of presentation; and the dura-
tion of incubation (Mogasale 2016). Bone marrow culture gives
a higher culture-positive rate, probably because the concentration
of organisms is higher than in the blood, and may remain positive
even after antibiotic therapy has been started (Wain 2001). Bone
marrow culture is positive in 80% to 95% of patients with enteric
fever, including in patients who have been taking antibiotics for
several days regardless of the duration of the illness (Parry 2002).
Although bone marrow culture is more sensitive, it is difficult to
obtain, relatively invasive, and is of little use in public health set-
tings (Wain 2001). Even with sophisticated laboratories, confirm-
ing the diagnosis of enteric fever can be difficult with negative
blood or bone marrow cultures despite a patient actually having
enteric fever (Baker 2010).
It is quite possible that RDTs are more sensitive than the current
reference standards for enteric fever. If laboratory isolation of the
causative organisms is neither cost-effective nor reliable, then there
is a potential role forRDTs to replacemicrobiological culture as the
main diagnostic test (Parry 2011). If no single reference standard
test exists, use of a composite reference standard (CRS) could
improve estimation of diagnostic test accuracy (Storey 2015).
O B J E C T I V E S
To assess the diagnostic accuracy of commercially available rapid
diagnostic tests (RDTs) and prototypes for detecting Salmonella
Typhi or Paratyphi A infection in symptomatic persons living in
endemic areas.
Secondary objectives
• To identify which types and brands of commercial test best
detect enteric fever.
• To investigate the sources of heterogeneity between study
results (see the ’Investigations of heterogeneity’ section).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included the following types of studies.
• Randomized controlled trials (RCTs) in which patients are
randomized to one of several index tests and all receive a
reference standard.
• Paired comparative trials in which a series of patients receive
two or more index tests and a reference standard.
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• Prospective cohort studies in which a series of patients from
a given population are recruited and receive one or more index
test and a reference standard.
• Retrospective case control studies that compare a group of
patients with laboratory-confirmed enteric fever cases (positive
reference standard) and a group of patients without enteric fever
(negative reference standard). In case control design studies, we
only extracted data relating to the index test(s) from control
groups participants with fever, and not from healthy control
participants without fever.
Participants
Patients living in enteric fever-endemic areas attending a healthcare
facility with fever were eligible. Thismay ormay not have included
patients with a clinical suspicion of enteric fever.
When only a subgroup of participants in a study was eligible for
inclusion in the review, we included the study provided that we
were able to extract relevant data specific to that subgroup. Sub-
groups included participants enrolled as separate groups, for ex-
ample a clinical cohort subgroup without healthy control patient
subgroup (Fadeel 2011).
Index tests
All rapid diagnostic tests (RDTs) specifically designed to detect
enteric fever cases. We categorized the tests as follows.
• RDTs that were applied to blood samples (venous or
capillary) to detect antigens.
• RDTs that were applied to blood samples (venous or
capillary) to detect antibodies (IgG, IgM, or both).
• RDTs that were applied to urine samples to detect antigens.
• RDTs that were applied to urine samples to detect
antibodies (IgG, IgM, or both).
We classified the RDTs further by format, for example, lateral flow,
flow-through, agglutination, or solid phase kits.
Studiesmay have compared one ormore RDT against one ormore
reference standard.
Target conditions
• Typhoid fever caused by Salmonella enterica serovar Typhi.
• Paratyphoid fever caused by Salmonella enterica serovar
Paratyphi A.
Reference standards
Studies were required to diagnose enteric fever using one of the
following reference standards.
• Bone marrow culture.
• Peripheral blood culture, peripheral blood PCR, or both.
We defined a Grade 1 study as one that used both bone marrow
culture and peripheral blood culture as the reference standard. In
Grade 1 studies, we considered either bone marrow or peripheral
blood culture positivity a positive reference standard.
Wedefined aGrade 2 study as one that used either peripheral blood
culture only as the reference standard, or peripheral blood culture
and peripheral blood PCR as the composite reference standard. In
Grade 2 studies, we considered either blood culture or blood PCR
positivity a positive composite reference standard.
As overall estimates of accuracy ignoring the use of different ref-
erence standards are difficult to interpret, we reported the results
separately for each grade of reference standard (Reitsma 2009).
Search methods for identification of studies
We attempted to identify all relevant studies regardless of language
or publication status (published, unpublished, in press, or ongo-
ing).
Electronic searches
We searched the following databases using the search terms and
strategy described in Appendix 1: the Cochrane Infectious Dis-
eases Group Specialized Register (4 March 2016); MEDLINE
(OVID, 1966 to 1 March 2016); Embase (OVID, 1974 to 4
March 2016); Science Citation Index-expanded (Web of Science,
1900 to 4 March 2016), IndMED; African Index Medicus, and
LILACS (1982 to 4 March 2016). We also searched Clinical-
Trials.gov and the World Health Organization (WHO) Interna-
tional Clinical Trials Registry Platform (ICTRP) (www.who.int/
trialsearch). for trials in progress, using “typhoid”, “paratyphoid”,
“enteric fever”, “rapid diagnostic test”, “RDT”, and “diagnostics”
as search terms.
Searching other resources
We checked the reference lists of all studies identified by the above
methods, and we manually searched World Health Organization
(WHO) reports. In addition we manually searched papers from
the 3rd (1997) to the 7th (2009) International Conferences on
Typhoid Fever and other Salmonellosis. We contacted test manu-
facturers to identify ongoing or unpublished studies.
Data collection and analysis
Selection of studies
One review author (LW) screened the titles and abstracts of arti-
cles identified by the search strategy. We coded articles that did
not fulfil the inclusion criteria as ’do not retrieve’. In the case of
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potentially eligible articles or if we were unclear whether the ar-
ticles met the inclusion criteria or not, we coded these articles as
’retrieve’. We retrieved the full-text texts of articles in the ’retrieve’
category. Two review authors (LW and CMP) independently as-
sessed the full-text articles for inclusion and consulted a third re-
view author (SM) in case of disagreement. We listed all studies
excluded after full-text assessments and their reasons for exclusion
in the ’Characteristics of excluded studies’ section. We presented
the study selection process in a study flow diagram.
Data extraction and management
Two review authors (LW and CMP) independently extracted a
standard set of data from each study article (see Appendix 2), using
a pre-piloted specifically designed data extraction form. A third
review author (SM) cross checked the data extraction and resolved
any discrepancies by discussion with the two review authors (LW
and CMP). If information was missing or not clear, we contacted
the study investigators.
We extracted the number of true positives, true negatives, false
positives, and false negatives based only on the Salmonella enterica
serovars the test was designed to detect (Typhi or Paratyphi A) as a
2 x 2 table for each study along with the corresponding threshold
value. If data for multiple 2 x 2 tables were presented based on
more than one threshold for a single study, we extracted each table
and the threshold values. If this data (2 x 2 table) was also available
for a subgroup of patients in the study, we extracted this data if the
subgroup of patients was of interest (that is, grouped by patient
age). For studies that we only included a subgroup of participants
in the review, we only extracted this data and presented it for that
particular subgroup. In case control design studies, we restricted
negative controls to febrile participants, and we excluded healthy
control participants from the 2 x 2 table data.
Where a study applied multiple index tests or reference standards,
we extracted data for each test. Since blood culture, bone marrow
culture, and blood PCR are imperfect reference standards, where
possible we extracted the results of a composite reference standard
(blood culture and bone marrow culture, or blood culture and
blood PCR), such that we documented a negative result if bone
marrow culture, blood culture, PCR, or all three, were negative
(Reitsma 2009). We extracted the number of uninterpretable or
invalid test results.
For Moore 2014 and Maude 2015, two review authors (LW and
CMP) were the study authors, so one review author (SM) inde-
pendently extracted data using individual participant data (from
CMP) as we could not extract ideal data for review from the pub-
lished articles. In Fadeel 2011, the article did not report results
summarized across the cohort. For both Typhidot and TUBEX
tests, for nested case control results within a cohort of patients, we
back calculated 2 x 2 tables to reflect cohort composition (see the
’Strengths and weaknesses of the review’ section).
Assessment of methodological quality
Two review authors (LW and CMP) independently assessed the
quality of each individual study using a modified QUADAS-2
tool (Whiting 2003; see Appendix 3). We answered each quality
indicator on the checklist with a ’yes’, ’no’, or ’unclear’ response
for each study, and we provided the reason for our judgment.
Statistical analysis and data synthesis
We entered all 2 x 2 table data from all RDTs in included arti-
cles into Review Manager 5 (RevMan 5) (Review Manager 2014),
which calculates sensitivity and specificity with 95% confidence
intervals (CIs). We used forest plots and summary receiver oper-
ating characteristic (SROC) plots to present the variation in sen-
sitivities and specificities between studies. In the description of
studies we recorded the number of uninterpretable or invalid test
results.
The statistical analysis focused on sensitivity and specificity at av-
erage operating points for the three main commercially-available
RDTs and their prototypes: TUBEX; Typhidot (including Typhi-
dot-M); and Test-it Typhoid (and KIT prototypes). We included
each test in a separate meta-analysis. For other tests we identified
fewer than four studies, so we did not complete any meta-analy-
sis summary. Where sufficient data were available, we performed
meta-analyses to estimate and compare the performance of the
tests.
For Test-It Typhoid and prototypes (KIT) studies, we performed
a meta-analysis for the threshold of > 1+ only as this was the
manufacturer’s recommendation. Data from the same study may
contribute to different comparisons (for example, RDT versus
blood culture; RDT versus bone marrow and blood culture), but
we only combined one set of data from each study in an individual
meta-analysis.
For meta-analysis we used the bivariate random-effects models of
sensitivity and specificity (Reitsma 2005; Chu 2006).We exported
the data from RevMan 5 (Review Manager 2014) into STATA
models fitted using xtmelogit with all three main test types in-
cluded in a single model allowing for unequal variances between
tests and allowing correlation of sensitivity and specificity for each
test in the random effects.Within xtmelogit we calculated pairwise
comparisons of the difference between sensitivity and difference in
specificity with 95% CIs of the three tests. We also used xtmelogit
for heterogeneity analyses to compare sensitivity and specificity for
the subgroup of studies where the Typhidot test reported indeter-
minate test results or not. We entered meta-analysis parameter es-
timates (bivariate model parameter estimates and confidence and
prediction region parameters) into RevMan 5 (Review Manager
2014).
For PanBio Multi-test Dip-S-Tick, Mega Salmonella, and SD Bi-
oline tests, where the only included data is from comparisons of
tests with fewer than four studies, we compared individual tests
with results from Typhidot and TUBEX on the same participants
8Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
as available.We based comparisons on conservative estimates from
unpaired comparisons of proportions, as paired data were not
available from articles. Where 95% CIs did not overlap between
test estimates, we established statistical significance without formal
testing. Where 95% CI overlapped, we reported the differences in
unpaired proportions with 95% CIs for the differences.
Investigations of heterogeneity
As part of the Secondary objectives, we planned to investigate
the sources of heterogeneity between study results, including the
following.
• Salmonella enterica serovars (Typhi or Paratyphi A).
• Study design (see ’Types of studies’).
• Test population (patients with a clinically-suspected
infection of typhoid or paratyphoid, or unselected febrile
patients).
• Reference test (Grade 1 or Grade 2 - see ’Reference
standards’).
• Index test format (for example, lateral flow versus
agglutination; IgM versus IgG versus IgM-IgG combination).
• Index test sample (blood versus urine participant sample).
• Level of disease endemicity (for example, medium versus
high) (Crump 2004).
• Participant characteristics (for example, adults versus
children).
• Geographical location (by sub-Saharan Africa versus the
rest of the world).
The rationale for distinguishing sub-Saharan Africa from the rest
of the world was that non-typhoidal Salmonellae (NTS) are an im-
portant cause of bacteraemia in sub-Saharan Africa (Parry 2011),
and may affect the performance of enteric fever RDTs in these
settings.
Sensitivity analyses
There was insufficient data to carry out sensitivity analyses to assess
the robustness of the meta-analyses based on quality components.
Assessment of reporting bias
We did not attempt to assess reporting bias.
R E S U L T S
Results of the search
We have summarized the study selection process in a PRISMA
flow-chart (Figure 1). We performed a literature search up to 4
March 2016 and identified a total of 2885 titles and abstracts.
There were 2411 articles after we removed duplicates.We retrieved
95 full-text articles for assessment. From the total number of 95
full-text articles retrieved and assessed, we included a total of 37
studies for qualitative analysis in the Cochrane Review.We did not
include two of the studies (Anagha 2012 and Anusha 2011) in the
quantitative analysis as together theywere not powered sufficiently
for a meta-analysis of the single index test (EnterocheckWB) they
evaluated (Table 1; Figure 2). The number of included studies in
the quantitative analysis after full-text assessment was 35.
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Figure 1. PRISMA flow diagram.
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Figure 2. Summary receiver operating characteristic plot: Enterocheck WB, PanBio, SD Bioline, Mega
Salmonella, Multi-Test Dip-S-Tick.
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Most included studies recruited participants from the Asia-Pa-
cific. The South Asian study locations included: India (10 stud-
ies); Bangladesh (five studies); and Pakistan (four studies). In
South-East Asia, the study locations included: Indonesia (five
studies); Vietnam (two studies); Malaysia (one study); Cambodia
(one study); Thailand (one study), and Papua New Guinea (one
study). East Asian countries included China (one study) and the
Philippines (one study). From Africa, two studies were from the
north (Egypt), and five studies were from sub-Saharan countries
(Kenya, Tanzania, Zimbabwe, and South Africa) where non-ty-
phoidal Salmonellae (NTS) are also an important cause of bacter-
aemia. Six studies recruited patients from areas of medium enteric
fever endemicity (Crump 2004). Most study participants were
from areas considered highly endemic for enteric fever (Crump
2004).
Eighteen of the studies included both adults and children, and
seven studies included children only. The age distribution of re-
cruited patients was not clear in 14 of the included studies. Thirty-
three studies included participants attending a tertiary healthcare
facility, 15 studies included secondary (district) healthcare atten-
dees, and seven studies included primary healthcare attendees.
Twenty studies recruited inpatients, 12 studies recruited outpa-
tients, while 10 studies did not state the point of recruitment.
All of the RDTs evaluated were antibody tests on blood designed
to detect S. Typhi infection. None of the included studies evalu-
ated a RDT that detected S. Paratyphi A infection. All the RDTs
evaluated used venous blood as the biological sample with one
study additionally using capillary blood samples (Anusha 2011).
There were no suitable studies that evaluated RDTs using other
biological samples such as saliva or urine.
The included studies evaluated 13 index tests in total (Table 1).
The most commonly evaluated RDTs were Typhidot and its vari-
ants (Typhidot; Typhidot-M; TyphiRapid Tr-02; Malaysian Bio-
diagnostic Research SDN BHD, Malaysia) in 22 studies, and
TUBEX TF (IDL Biotech, Sollentuna, Sweden) in 14 studies.
An index test created by the Royal Tropical Institute, Amsterdam
(KIT), and now commercially available as the Test-it-Typhoid test
(LifeAssay Diagnostics, South Africa) was evaluated in three dif-
ferent test formats in nine studies (dipstick assay; latex aggluti-
nation assay; lateral flow immunochromatographic test (ICT)).
Other index tests evaluated included: Enterocheck WB (Zephyr
Biomedicals, Tulip Group, Goa, India) in two studies; Entero-
screen (Zephyr Biomedicals, Tulip Group, Goa, India); SD Bio-
line (Standard Diagnostics, Kyonggi-do, Korea);Mega Salmonella
(Mega Diagnostics, Los Angeles,USA); Multi-Test Dip-S-Tick
(PANBIO INDX Inc., Baltimore, USA); and Onsite Typhoid
IgG/IgM combo (CTK Biotech Inc., SanDiego, California, USA)
in one study each.
Methodological quality of included studies
We have summarized the methodological quality of the 37 in-
cluded studies in Figure 3. We extracted this data using a modi-
fied QUADAS-2 criteria proforma (Appendix 3) that focused on
four domains of methodological quality: patient selection; index
test; reference standard; and flow and timing. The domain with
the highest level of risk for bias across all studies was that of pa-
tient selection (> 50%). We have summarized the risk of bias and
the review authors’ judgements about the applicability concerns
of these domains for each included study in Figure 4.
Figure 3. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies.
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Figure 4. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study.
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Only 11 studies recruited unselected febrile patients. Most in-
cluded studies selected patients on the basis of a clinical suspi-
cion of enteric fever, although the criteria for suspecting enteric
fever were usually not stated. Only three studies employed the
Grade 1 reference standard, with blood and bone marrow culture
(Bhutta 1999; Gasem 2002; Khan 2002). All studied used pe-
ripheral blood culture. Three studies also used blood PCR (Siba
2012; Moore 2014; Maude 2015). One study used stool culture,
and another used theWidal Test in a composite reference standard
(Gopalakrishnan 2002; Pastoor 2008). Only half of the included
studies reported that the index test results were interpreted with-
out knowledge of the reference standard results. Patients were re-
cruited prospectively in 26 of the 37 included studies. Index tests
were performed retrospectively on stored samples in 18 studies.
Twenty-three studies reported enrolling a consecutive or random
group of patients (see the ’Characteristics of included studies’ sec-
tion). Sixteen studies used a case control design where diagnostic
accuracy results can be overestimated, although all these studies
reported results separately for control groups from febrile patients.
Nineteen studies used cohort (not case control) designs, and in
two studies the reporting was unclear.
Findings
Typhidot and its variants
Three variants of the Typhidot test were studied: Typhidot (17
studies); Typhidot-M (six studies); and TyphiRapid Tr-02 (one
study).
For theTyphidot test, indeterminate results canbe producedwhich
are classified as both IgM test negative but IgG test positive (Olsen
2004; Naheed 2008). Some studies explicitly classified indetermi-
nate results, where others did not clearly report indeterminate re-
sults (Siba 2012), or only presented the IgM data without the IgG
data (Khan 2002). We attempted to separately extract the IgM
and IgG positive data from each study and, where possible, used
the IgM data only to allow comparison of results between all three
types of Typhidot test by classifying the indeterminate results as
negative (see the ’Differences between protocol and review’ sec-
tion).
The study results plotted in receiver operating characteristic
(ROC) space are shown in Figure 5. The Typhidot variant studies
did not perform consistently across studies. Figure 6 shows the
forest plots of studies evaluating Typhidot RDTs by various test
type, and by whether indeterminate results were reported or not.
There is no obvious visually distinguishable trend in test perfor-
mance with prevalence across non-case control studies.
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Figure 5. Summary ROC Typhidot all test types.
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Figure 6. Forest plots for Typhidot all test types.
The included studies used three different grades of reference test:
Grade 1 (peripheral blood culture or bone marrow culture, or
both); Grade 2 (peripheral blood culture only); and Grade 2 (pe-
ripheral blood culture, nucleic acid amplification (blood PCR), or
both). To determine the impact of the reference test on accuracy,
we plotted the study results in ROC space according to the refer-
ence test used in Figure 7. In the study that used both blood cul-
ture alone, and blood culture combined with blood PCR on the
same patients (Siba 2012), use of the composite reference standard
of PCR and blood culture lowered test sensitivity results by about
25%.
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Figure 7. Summary receiver operating characteristic plot of tests: Typhidot and Typhidot-M by reference
test.Abbreviations: BC: blood culture; BM: bone marrow; BC & PCR: blood culture and polymerase chain
reaction.
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The median sample size of all studies of Typhidot and its variants
was 127 (range 50 to 1732). The earliest study was published
in 1999, with the remainder being published in the 2000s. The
latest study was published in 2016. Sensitivities ranged from 27%
to 100%, and specificities ranged from 38% to 99% (Figure 6).
The meta-analytical average sensitivity and specificity for all three
Typhidot test types were 84% (95% confidence interval (CI) 73%
to 91%) and 79% (70% to 87%) respectively based on 22 studies
(Summary of findings).However, based on the 13Typhidot studies
where indeterminates were reported or were not produced by the
test (Typhidot-M and TyphiRapid Tr-02) which have a lower risk
of bias, the average sensitivity was 78% (95%CI 65% to 87%) and
specificity was 77% (95% CI 66% to 86%). Comparing the 13
studies at lower risk of bias with the nine studies that did not report
indeterminates, the difference in sensitivity was −9.8% (95% CI
−26.1% to 6.4%) and specificity of −8.0% (95% CI −24.2%
to 8.3%). Studies where indeterminates were not reported are at
a higher risk of bias and have both higher average sensitivity and
specificity, although neither difference is statistically significant.
TUBEX
Fourteen studies evaluated TUBEX. We have presented the study
results plotted in ROC space and as a forest plot in Figure 8 and
Figure 9, which illustrate heterogeneity in test performance be-
tween studies. All included studies were Grade 2 (peripheral blood
culture only as reference standard), with one study using both
blood culture and blood PCR (Siba 2012). This heterogeneity is
mirrored when the TUBEX test results are presented by those with
and without a case control study design (Figure 10). One study
used two different reference tests (Figure 11). As with the Typhi-
dot studies, the composite reference standard of blood culture and
PCR lowered sensitivity by around 25%.
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Figure 8. Summary receiver operating characteristic plot of test: TUBEX. Reference test: Blood culture.
One result per study.
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Figure 9. Forest plot of TUBEX. Reference test blood culture.
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Figure 10. Summary receiver operating characteristic plot: TUBEX by case control design.Abbreviation:
BC: blood culture.
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Figure 11. Summary receiver operating characteristic plot: TUBEX by reference testAbbreviations: BC:
blood culture; BC & PCR: blood culture and polymerase chain reaction.
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The median sample size was 158 (range 73 to 1732). The earliest
study was published in 2001, and the most recent study published
in 2016. Sensitivities ranged from 56% to 100%, and specificities
ranged from 69% to 96% (Figure 9). The meta-analytical average
sensitivity and specificity (95% CI) were 78% (71% to 85%) and
87% (82% to 91%) respectively (Summary of findings).
Test-It Typhoid and Royal Tropical Institute (KIT)
prototypes
Nine studies evaluated the performance of the Test-it Typhoid
index test and its earlier KIT prototype formats: five as a dipstick
assay; one as a latex agglutination test; and three as the ICT lateral
flow assay. The KIT ICT lateral flow assay is now commercially
available as Test-It Typhoid (LifeAssay) and two studies evaluated
this (Moore 2014; Maude 2015). In the dipstick and lateral flow
assay formats, the test gives a semi-quantitative result scored as
1+, 2+, 3+, or 4+ dependent on the intensity of the band on
the test strip. The manufacturer’s recommended threshold that is
considered positive is 1+ or more. A few studies have additionally
evaluated a threshold of 2+ or more.
All studies evaluating this test plotted in ROC space by different
test types (1+ result classified as positive) are presented in Figure
12. Although the dipstick and ICT RDTs appear to perform bet-
ter with higher average sensitivities, most studies adopted a case
control design (Figure 13).
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Figure 12. Summary receiver operating characteristic plot: KIT all test types. Threshold > 1+.
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Figure 13. Forest plot of tests: KIT Threshold > 1+ by test type. Reference test: blood culture.
The results for both thresholds (1+ versus 2+whenwe could extract
these results from the same study) are illustrated in Figure 14.
Increasing the threshold to greater or equal to 2 (≥ 2+) decreases
the sensitivity of the index test but increases the specificity. One
study suggested the diagnostic accuracy was improved by using a
threshold of 2+ or more (Moore 2014).
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Figure 14. Summary receiver operating characteristic plot: KIT test by threshold > 1+ and > 2+.
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Included studies evaluated these assays against different reference
standards: Grade 2 (peripheral blood culture only); and Grade 2
(peripheral blood culture and blood PCR) (Moore 2014; Maude
2015). One study was a Grade 1 study (peripheral blood culture,
or bone marrow culture, or both) although less than half (61/127)
had a bone marrow culture performed, with the remainder using
blood culture only as the reference standard (Gasem 2002). Figure
15 illustrates the performance of the ICT lateral flow assay by
these different reference standards. Figure 16 present study results
according to case control or non-case control design.
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Figure 15. Summary receiver operating characteristic plot: KIT ICT by reference test.Abbreviations: BC:
blood culture; BC & PCR: blood culture and polymerase chain reaction.
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Figure 16. Summary receiver operating characteristic plot: KIT by case control (All test types. Threshold
>1+).
Combining all different formats, the median sample size was 300
(range 85 to 502). Studies were published from 2001 to 2015.
Sensitivities ranged from 42% to 92%, and specificities ranged
from 61% to 97% (Figure 13). The meta-analytical average sen-
sitivity and specificity across all nine studies of KIT RDTs based
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on a threshold of > +1 was 69% (95% CI 59% to 78%) and 90%
(95% CI 78% to 93%) respectively (Summary of findings).
Comparisons between index tests
When comparing the three main tests (Typhidot, TUBEX, and
Test-it Typhoid (KIT ICT)) we used two different groups of com-
parator Typhidot test because of the risk of bias introduced when
studies at risk of indeterminates do not report whether indeter-
minates were present or how they were treated in study results.
Our primary analysis related to all Typhidot tests (based on 22
studies) with a sensitivity analysis based on restricting to the 13
Typhidot studies with lower risk of bias due to clear reporting of
indeterminates.
Using all 37 studies including all 22 studies with Typhidot results
to compare Typhidot, TUBEX, and Test-It Typhoid (KIT) tests,
TUBEXhad a 10%higher average sensitivity thanTest-It Typhoid
(KIT) (95% CI −1.6% to 21.7%) although this was not a statis-
tically significant difference. The specificity was similar between
tests with TUBEX having a slightly lower average specificity of
0.5% (95% CI −7.7% to 8.9%). This also was not a statistically
significant difference.
Comparing Typhidot to Test-It Typhoid (KIT), there was a statis-
tically significant difference in average sensitivity when compared
to all Typhidot tests (Typhidot higher sensitivity 15.0%, 95% CI
2.0% to 28.1%) but the difference in sensitivity was not statisti-
cally significant when Test-It Typhoid was compared to Typhidot
tests with a lower risk of bias, due to clear reporting of indetermi-
nates (9.3%, 95% CI −5.2% to 23.7%). The differences in aver-
age specificity were not statistically significant for either compar-
ison (22 Typhidot studies: lower Typhidot specificity of −7.6%,
95% CI −18.6% to 3.4%; 13 Typhidot studies: lower Typhidot
specificity of −9.5%, 95% CI −21.5% to 2.4%).
Comparing Typhidot to TUBEX, Typhidot had a slightly higher
average sensitivity when all studies were compared to TUBEX
but this was not statistically significant (5.0%, 95% CI −6.1%
to 16.1%). When TUBEX was compared to Typhidot tests with
a lower risk of bias due to clear reporting of indeterminates, Ty-
phidot had a slightly lower, but not significant, average sensitivity
(−0.7%, 95% CI−13.6% to 12.0%). The average specificity was
lower for Typhidot compared with TUBEX based on all studies
(−8.2%, 95% CI−17.7% to 1.4%) and based on Typhidot stud-
ies with lower risk of bias due to clear reporting of indeterminates
(−10.1%, 95% CI −20.6% to 0.5%). In neither case was the
difference in specificity statistically significant.
Paired comparisons between index tests
Direct comparison of diagnostic tests in the same patients in the
same study provides the highest level of evidence to compare tests
(Rutter 2001; Takwoingi 2013).
Eleven studies compared different RDTs within the same study.
There were 10 paired comparisons of Typhidot/Typhidot-M and
TUBEX (Figure 17), and one study compared TUBEX and Test-
It Typhoid (and KIT prototypes) (House 2001), although it is un-
clear whether or not these were on the same patients (Figure 18).
There were no paired comparisons of Test-It Typhoid (and KIT
prototypes) and Typhidot tests. There was no statistically signifi-
cant difference in either average sensitivity nor average specificity
between Typhidot and TUBEX tests, with a lower sensitivity in
Typhidot (−7.6%, 95% CI −19.8% to 4.6%) and a lower speci-
ficity in Typhidot (−3.7%, 95% CI −13.9% to 6.5%). This is
supported by Figure 17, where no consistent direction is evident
for differences between these tests.
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Figure 17. Summary receiver operating characteristic plot: Typhidot versus TUBEX. Paired studies only.
One result per index test per study.
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Figure 18. Summary receiver operating characteristic: TUBEX versus KIT. Paired results. One result per
index per study.
Other RDT evaluations
There were seven other commercial RDTs that were evaluated
by only 1, 2, or 3 studies, and therefore we did include them in
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the meta-analyses (’Methodological quality of included studies’
section). We have presented the results of these individual studies
and tests in the ’Data and analyses’ section and Figure 2. Further
research is needed before there is sufficient data to recommend
these tests. From the current studies, the most promising tests are
Enterocheck WB, Enteroscreen, and PanBio.
Enterocheck WB was not compared with any other index tests in
the two included studies (Anusha 2011; Anagha 2012), so only
lower quality indirect evidence is available to compare test perfor-
mance to other tests (Figure 2). For both studies, both sensitiv-
ity and specificity were reasonably high (Anagha 2012: sensitivity
89%, 95% CI 67% to 99%; specificity 97%, 95% CI 89% to
100%; Anusha 2011: sensitivity 85%, 95% CI 73 to 94%; speci-
ficity 89%, 95% CI 85% to 92%).
Enteroscreen was only tested in one case control study (Prasad
2015), where it was compared to Typhdot in overlapping partic-
ipants. In this single case control study, Enteroscreen had a sig-
nificantly lower sensitivity (Typhidot higher sensitivity based on
conservative estimate of unpaired proportions; difference in sen-
sitivity 9%, 95% CI 3% to 16%) but a significantly higher speci-
ficity (Typhidot lower specificity; difference 17%, 95% CI 14%
to 20%).
Gopalakrishnan 2002 tested both PanBio and Typhidot in the
same study. While the sensitivity of the tests was similar (78% and
82% respectively), the specificity of PanBio was superior in this
study (81% versus 68%; 13% difference in conservative unpaired
proportions with 95% CI 0.6% to 25%. We noted that there was
insufficient data for more appropriate paired comparison).
Multi-test Dip-S-Tick was tested in the same study participants
as TUBEX and Typhidot (Olsen 2004). There was no significant
difference in sensitivity between the tests, but a clinically and sta-
tistically inferior specificity in Multi-test-Dip-S-Tick (specificity:
50%, 95% CI 26% to 74%) compared in the same participants
with both TUBEX (TUBEX higher specificity; difference in speci-
ficity of 44%, 95% CI 19% to 69%) and Typhidot (Typhidot
higher specificity; difference in specificity of 39% (95% CI 12%
to 66%).
A single study compared Mega Salmonella to Typhidot, TUBEX,
and SDBioline using the same participants (Kawano 2007).Mega
Salmonella had superior sensitivity to Typhidot and SD Bioline
but significantly lower specificity (the 95% CI for specificity did
not overlap with those from TUBEX or SD Bioline). In this study
TUBEXhas similar sensitivity toMega Salmonella (95%and 91%
respectively) and significantly higher specificity (80%, 95% CI
71 to 88) versus 49% (95% CI 39 to 59) respectively). Mega
Salmonella had an inferior performance to TUBEX, SD Bioline,
and Typhidot, although this was only based on evidence from one
included study.
Three included studies evaluated SD Bioline (Kawano 2007;
Limpitikul 2014; Maude 2015), and all three studies reported the
preferred IgM test format. In Kawano 2007, SD Bioline IgM had
an inferior performance to TUBEX when tested on the same par-
ticipants. SD Bioline had significantly lower sensitivity to TUBEX
(51% (95% CI 58% to 72%) versus 95% (95% CI 87% to 99%)
respectively) and similar specificity (76%versus 80% respectively).
In Maude 2015, SD Bioline IgM had significantly lower sensitiv-
ity at 21% (95% CI 9% to 38%) compared to both Test-It Ty-
phoid (Life Assay) and Onsite Typhoid (CTK Biotech), both with
a reported sensitivity of 59% (95% CI 41% to 75%), indicated as
the 95% CIs did not overlap.
Two included studies assessed Onsite Typhoid (CTK Biotech). In
Maude 2015, it was compared with both Test-It Typhoid (Life As-
say) and the SD Bioline test. Onesite Typhoid had similar results
to the Test-It Typhoid test, which were superior in sensitivity to
SD Bioline. However, SD Bioline had significantly higher speci-
ficity (97%, 95% CI 95% to 99%) than both Test-It Typhoid test
(61%, 95% CI 55% to 67%) and Onsite Typhoid (74%, 95% CI
68% to 79%). Tarupiwa 2015 evaluated Onsite Typhoid along-
side TUBEX, where the performances of both tests were closely
comparable. We note that these results are based on two studies
and further research is needed.
Heterogeneity
There were insufficient studies for formal heterogeneity analysis
using meta-analysis of test subgroups, except for a comparison of
Typhidot test studies at lower risk of bias due to clear reporting of
indeterminate results. For other potential sources of heterogeneity
(’Investigations of heterogeneity’ and ’Secondary objectives’ sec-
tions) where individual study characteristics could be investigated,
such as study design, prevalence, and study reference standard, we
presented results for visual examination of heterogeneity in sum-
mary ROC (SROC) plots and forest plots.
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Summary of findings
Review question: to assess the diagnost ic accuracy of rapid diagnost ic tests (RDTs) for detect ing enteric fever in persons living in endemic areas present ing to a healthcare
facility with fever
Patients/ population: clinically-suspected enteric fever pat ients or unselected febrile pat ients
Role: f irst test for enteric fever in pat ients present ing to a healthcare facility with fever in endemic areas
Index tests: all RDTs specif ically designed to enteric fever cases applied to pat ient blood or urine samples
Reference standards: bone marrow culture, peripheral blood culture, peripheral blood culture, and polymerase chain react ion (PCR) on blood
Studies: prospect ive cohort , retrospect ive case control
Setting: healthcare facility in enteric fever endemic areas
Index test Effect (95% confidence
interval (CI))
Participants
Total number, number
with disease, (number
of studies)
Test result Number of results per 1000 participants tested1(95% CI)
Prevalence 1% Prevalence 10% Prevalence 30%
Typhidot
(all types)
Sensit ivity 84 (73 to 91)
Specif icity 79 (70 to 87)
6928, 982 (22) TP
FN
FP
TN
8 (7 to 9)
2 (1 to 3)
208 (129 to 297)
782 (693 to 861)
84 (73 to 91)
16 (9 to 27)
189 (117 to 270)
711 (630 to 783)
252 (219 to 273)
48 (27 to 81)
147 (91 to 210)
553 (490 to 609)
Typhidot indeter-
m inants reported or not
applicable
Sensit ivity 78 (65 to 87)
Specif icity 77 (66 to 86)
5555, 662 (13) TP
FN
FP
TN
8 (7 to 9)
2 (1 to 3)
228 (139 to 337)
762 (653 to 851)
78 (65 to 87)
22 (13 to 35)
207 (126 to 306)
693 (594 to 774)
234 (195 to 261)
66 (39 to 105)
161 (98 to 238)
539 (462 to 602)
Typhidot indeterm inate
results reported
Sensit ivity 66 (59 to 73)
Specif icity 81 (58 to 93)
1721, 339 (6) TP
FN
FP
TN
7 (6 to 7)
3 (3 to 4)
188 (69 to 416)
802 (574 to 921)
66 (59 to 73)
34 (27 to 41)
171 (63 to 378)
729 (522 to 837)
198 (177 to 219)
102 (81 to 123 )
133 (49 to 294)
567 (406 to 651)
TUBEX Sensit ivity 78 (71 to 85)
Specif icity 87 (82 to 91)
4885, 627 (14) TP
FN
FP
TN
8 (7 to 9)
2 (2 to 3)
129 (89 to 178)
861 (812 to 901)
78 (71 to 85)
22 (15 to 29)
117 (81 to 162)
783 (738 to 819)
234 (213 to 255)
66 (45 to 87)
91 (63 to 126)
609 (574 to 637)
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Test-it Typhoid and KIT
prototypes (threshold >
1+)
Sensit ivity 69 (59 to 78)
Specif icity 90 (78 to 93)
2828, 682 (9) TP
FN
FP
TN
7 (6 to 8)
3 (2 to 4)
99 (69 to 218)
891 (772 to 921)
69 (59 to 78)
31 (22 to 41)
90 (63 to 198)
810 (702 to 837)
207 (177 to 234)
93 (66 to 123)
70 (49 to 154)
630 (546 to 651)
Attributes of tests contributing to benefits and risks
Rapid diagnost ic tests
(RDTs)2
RDTs are designed to provide test results typically in less than 1 hour, whereas current ly used blood culture tests require 48 hours. The technical
ability needed to conduct these rapid tests is designed to be lower than typical laboratory based tests, meaning they have the potent ial to be delivered
nearer to the pat ient, further reducing t ime to diagnosis. However, some variants of the Typhidot test requires addit ional laboratory equipment,
whereas the TUBEX and Test-it Typhoid test do not. The TUBEX tests and some variants of Typhidot require cold chain storage. The Test-it Typhoid
test does not. In this Cochrane Review all included rapid tests were used on blood samples. None of the included studies conducted tests on urine
samples
Overall certainty of evidence
Indeterminate results: f or the Typhidot index test, there are concerns about studies which do not report indeterm inate results (IgM negative and IgG posit ive). These results
can f requent ly occur and if these results are not included in the analysis this biases study results to be overly-opt im ist ic
Case control studies: many of these studies use a case control design. This study design is at risk of overest imating both sensit ivity and specif icity
Reference standard: the highest grade of reference standard includes either bone marrow culture or PCR using blood, in addit ion to blood culture. However using bone marrow
as a reference standard is invasive and more severe pat ients may be selected into these studies. Most included studies use only blood culture, and studies using more than 1
reference standard for example, PCR showed a reduct ion in RDT sensit ivity by 20% to 25%
Precision: average est imates of both sensit ivity and specif icity have low precision, due to the heterogeneity between studies
Paired studies: there are few paired studies, where more than 1 test is used in the same patients. These studies provide the most direct evidence for comparing tests
Typhidot paired with TUBEX: Total 4245, 484 pat ients with disease
Typhidot paired with Test-it Typhoid and KIT prototypes: no paired studies
Test-it Typhoid and KIT prototypes paired with TUBEX: total 127, 64 pat ients with disease. It remains unclear if the tests were used in the same cohort of pat ients
Abbreviat ions: False Negatives (FN); False Posit ives (FP); immunoglobulin-G (IgG); immunoglobulin-M (IgM); Royal Tropical
Inst itute, Amsterdam (KIT); polymerase chain react ion (PCR); True Negatives (TN); True Posit ives (TP).
1We used 2 systematic reviews of bacteraemia in Asia and Af rica to inform prevalences of 30% (Asia); 10% (Af rica: adults
and children) and 1% (Af rica: children) (Reddy 2010; Deen 2012).
2Keddy 2011.
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D I S C U S S I O N
The principal findings of this systematic review were that the diag-
nostic accuracy of the three main groups of commercially available
rapid diagnostic tests (RDTs) for enteric fever (Typhidot and its
variants, TUBEX, Test-It Typhoid and prototype (KIT) tests) was
moderate. There was no statistically significant difference in the
average sensitivity between Typhidot, TUBEX, or Test-It Typhoid
tests, except when we compared all Typhidot tests to Test-It Ty-
phoid (84% all Typhidot studies, 78% Typhidot studies with low
risk of bias due to clear reporting of indeterminates, 78%TUBEX,
69% Test-It Typhoid). There was no statistically significant differ-
ence for average specificity between these tests (79% all Typhidot
studies, 77% Typhidot with low risk of bias due to clear report-
ing of indeterminates, 87% TUBEX, 90% Test-It Typhoid); see
’Summary of findings’ table 1 (Summary of findings).
A clinically useful test requires high values for both sensitivity and
specificity. There was no statistical evidence to demonstrate that
one group of tests was significantly better than the other (Figure
17; Figure 18; Figure 19; Figure 20; Figure 21). The quality of
studies that evaluated the diagnostic accuracy of RDTs for enteric
fever was generally low. Only three of the 37 included studies
used the Grade 1 reference standard requiring a bone marrow and
blood culture result, and less than one-third of studies recruited
unselected febrile patients.
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Figure 19. Summary receiver operating characteristic plot: Typhidot versus TUBEX tests. One result per
index test per study.
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Figure 20. Summary receiver operating characteristic plot: TUBEX versus Test-it Typhoid (KIT) tests. One
result per index test per study.
38Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Figure 21. Summary receiver operating characteristic: Typhidot versus KIT. No paired studies. One result
per index per study.
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In a hypothetical cohort of 1000 patients presenting with fever
where 30% (300 patients) have enteric fever: on average, and based
on all the test results, Typhidot will miss the diagnosis in 48 of the
300 patients with enteric fever (66missed based on Typhidot stud-
ies with low risk of bias due to clear reporting of indeterminates);
TUBEX will miss 66; and Test-It Typhoid and prototype (KIT)
tests will miss 93. In the 700 people without enteric fever the av-
erage number of patients with a false positive diagnosis of enteric
fever would be 147 with Typhidot tests, (161 in Typhidot tests
with low risk of bias due to clear reporting of indeterminates), 91
with TUBEX, and 70 with Test-It Typhoid and prototype (KIT)
tests. The target product profile of an enteric fever RDT has not
been defined. A sensitivity of > 90% and specificity of > 95% are
probably minimum targets. In our hypothetical cohort of patients
a test with our minimum target product profile would miss on
average 30 of 300 enteric fever patients and give a false positive
diagnosis in 35 of 700 without enteric fever.
RDTs for other febrile illnesses, such as malaria and dengue, al-
ready have been tested extensively in standardized evaluations that
have provided an evidence base for World Health Organization
(WHO) guidance and for the diagnostic algorithms used in en-
demic regions (WHO 2009; Abba 2011). The diagnostic tests for
acute enteric fever have not been evaluated with the same rigorous
methods. A diagnostic test to detect chronic (asymptomatic) car-
riers and individuals who have had prior exposure to the causative
pathogens may also be of considerable epidemiological value. Such
tests could potentially strengthen surveillance programmes aimed
at identifying populations with a high-burden of enteric fever that
might benefit from vaccination initiatives (Andrews 2015). The
lack of such diagnostics obscures the true burden and impact of the
disease; crucial information needed for policymakers, Ministries
of Health, and others (Baker 2010; Crump 2014).
It is important to highlight the heterogeneity among the included
studies. Patient selection (unselected febrile patients versus those
suspected to have enteric fever) is a major source of heterogeneity.
The variation in how indeterminate results in evaluations of Ty-
phidot (IgG positivity, IgM positivity, or both) were treated and
reported was also considerable (see the ’Strengths and weaknesses
of the review’ section). Most included studies took place in ter-
tiary centres in South-Asian settings highly endemic for enteric
fever. There were also studies set in medium-endemic regions but
relatively few in sub-Saharan Africa (Crump 2004).
Thriemer review
Thriemer and colleagues published a systematic review of TUBEX
and Typhidot for the diagnosis of acute enteric fever (Thriemer
2013). They reported ameta-analysis average sensitivity and speci-
ficity of TUBEX of 69% (95% CI 45% to 85%) and 88% (95%
CI 83% to 91%) respectively. The Thriemer review authors also
reported Typhidot sensitivity and specificity estimates of between
56% and 84% and 31 and 97% respectively (Thriemer 2013).
They did not perform a meta-analysis for Typhidot due to the
limited data available. These results are comparable to the findings
of this Cochrane Review: TUBEX sensitivity of between 71% to
85% and specificity 82% to 91%; Typhidot sensitivity 73% to
91% and specificity 70% to 87% (Summary of findings). There
are however a number of methodological differences between the
two reviews.
Thriemer 2013 only included studies that used a commercial
blood culture system with automated detection of positive cul-
tures, and excluded studies using an ’in-house’ blood culture sys-
tem with manual detection of positive cultures. The number of
studies of these tests using commercial blood culture systems was
limited, which meant a meta-analysis was not possible. Commer-
cial blood culture systems ensure that the reference test has been
performed in a consistent and quality assured manner. If the ’in-
house’ blood culture system employs acceptedmedia formulations
and is subjected to appropriate quality control testing, it should
be as sensitive as commercial systems (Wilson 1994). The ma-
jor difference between the commercial automated and ’in-house’
manual blood culture systems relates to the speed of result, with
the automated systems detecting bacterial growth earlier.
Thriemer 2013 did not include test accuracy data for the Typhi-
dot-M test. The Thriemer review authors explored various classi-
fications of how to treat the indeterminate results when describing
the statistical approach to analysing the Typhidot test data. In our
Cochrane Review we have included studies that looked at Typhi-
dot-M and classified indeterminate results as negative. To allow
a clearer comparison between the Typhidot and Typhidot-M test
results, we extracted the IgM antibody data from the Typhidot
studies when given in the report.
The Thriemer review only included commercially available RDTs
at the time of the literature search. We included the Test-it Ty-
phoid ICT lateral flow assay (LifeAssay Diagnostics), which is now
commercially available. This test was developed from several pro-
totype RDTs by the Royal Tropical Institute (KIT) in Amsterdam.
The Test-it Typhoid test and the KIT protypes all measure IgM
antibodies against an lipopolysaccharide (LPS) antigen in various
formats. In this review we have evaluated both the KIT prototypes
and the commercial RDT.
Reference standard
The evaluation of RDTs in enteric fever is complicated by the
lack of a suitable reference standard (Baker 2010). The quality
of the reference standard used in these studies affects the diag-
nostic accuracy results of each RDT. Combinations of peripheral
blood culture, bone marrow culture, and blood PCR positivity
have been used to indicate a true positive result (enteric fever case).
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If these reference tests are negative then we have described these
as a non-enteric fever case. Blood culture lacks sensitivity (WHO
2003; Mogasale 2016), so it is likely some of the culture-negative
patients will actually have enteric fever. It must be acknowledged
that culture-negative patients with a positive RDT result may ac-
tually be true positives rather than false positives. Most Grade 2
studies used blood culture only as the reference standard (Figure
7; Figure 11). The stronger studies were those where index tests
were evaluated against more than one different reference test (Siba
2012; Moore 2014). Studies with more robust reference standards
demonstrated reduced RDT sensitivity. The Grade 1 studies using
bone marrow culture were conducted in higher prevalence pop-
ulations (Khan 2002: 54%; Bhutta 1999: 47%), and perhaps in
those with more severe disease. This correlates with the reduced
index test performance in other high prevalence studies (Olsen
2004: 75%). In the TUBEX (Figure 7) and Typhidot (Figure 11)
studies, there seem to be a common 20% to 25% reduction in
sensitivity when the blood polymerase chain reaction (PCR) re-
sult was combined with blood culture as a composite reference
standard. PCR has the potential ability to increase the number of
typhoid cases identified by detecting dead bacteria or bacteria that
cannot be cultured (Massi 2005; Nga 2010). It appears that these
patients are less likely to be antibody positive in the RDTs, which
explains the decrease in sensitivity when a PCR reference test is
used.
Study design
The identification of studies that use or avoid a case control design
formed part of the assessment of methodological quality (Whiting
2003). Case control designs can introduce bias and increase appar-
ent accuracy as more severe disease is often compared to healthy
patients. Studies that avoid a case control design by recruiting
a cohort of unselected febrile patients have a lower risk of bias
relating to patient selection. Over a third (16) of the 37 studies
used a case control study design. Figure 22, Figure 10, and Figure
16 are receiver operating characteristic (ROC) plots for Typhidot,
TUBEX, and Test-It Typhoid and KIT prototypes respectively.
Each study is plotted indicating whether they adopted or avoided a
case control design. Across all three index test groups, case control
studies had higher apparent accuracy, with results having a higher
combination of sensitivity and specificity. This highlights the im-
portance of robust study designs in the evaluation of diagnostic
test accuracy.
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Figure 22. Summary receiver operating characteristic plot: Typhidot tests by case control design.
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Only 11 of the 37 included studies recruited unselected febrile pa-
tients. Most of the other studies used a clinical suspicion of enteric
fever as themajor entry criteria, but rarely specified the precise clin-
ical criteria used to suspect the disease. The choice of the optimum
non-disease control group is also difficult. Unselected febrile pa-
tients with another confirmed diagnosis are the optimum control
group, but difficult to recruit. Thriemer 2013 also discussed this
control group issue (Type 1 control). Patients with suspected en-
teric fever or non-specific fever but who are blood culture negative
are less satisfactory as a non-disease control group (Type 2 control)
and will decrease the apparent specificity of the test (Thriemer
2013). Cases in this group may actually have enteric fever despite
testing negative on both index and reference tests. In addition to
this, studies that analysed index tests in healthy afebrile controls
are likely to have overestimated specificity.
Comparisons between tests
Comparisons of diagnostic tests are typically based on a combina-
tion of both direct comparisons where the tests are compared in
the same patients, and indirect comparisons, where the tests being
compared are conducted on different patients. Direct comparisons
are at lower risk of bias as when the same patients at the same
time point are tested as patients are tested with the same disease
severity and comorbidities, and other features of study design that
may give rise to potential for bias are also the same.
We compared Typhidot, TUBEX, and Test-It Typhoid based on a
combination of direct and indirect test comparisons. We did not
detect any statistically significant difference between these tests
when the comparisons were based on Typhidot tests at lower risk
of bias due to clear reporting of indeterminates.
There were 11 studies with direct comparisons of different RDTs
within the same study (Figure 17; Figure 18). TUBEX and Ty-
phidot/Typhidot-M were the most common comparisons. There
was no statistical difference detected and no consistent direction
of difference found between these two groups of index tests (Ty-
phidot and variants versus TUBEX).
Summary of main results
We have summarized the main quantitative diagnostic test ac-
curacy results in ’Summary of findings’ table 1 (Summary of
findings).
• The number of high quality studies that evaluated the
diagnostic accuracy of RDTs for enteric fever was low, as many
studies adopted a case control study design.
• Only 3/37 included studies used the Grade 1 reference
standard of bone marrow culture.
• Less than one-third of the included studies (11/37)
recruited unselected febrile patients. Most used a clinical
suspicion of enteric fever as the major inclusion criterion.
• Most included studies (86%) recruited patients from the
Asia-Pacific region, and 50% of studies recruited from South
Asia.
• The three main groups of RDTs for enteric fever evaluated
were: Typhidot and its variants; TUBEX; and the Test-it
Typhoid test with its earlier dipstick/latex agglutination/lateral
flow assays prototypes developed by the Royal Tropical Institute
(KIT), Amsterdam.
• The diagnostic accuracy for enteric fever of the three main
RDT groups was moderate. TUBEX performed the most
consistently with moderate average sensitivity (78%) and better
specificity (87%), but when compared to Typhidot there was no
evidence to suggest that one was better than the other.
• The Test-it Typhoid tests and KIT protypes demonstrated
moderate sensitivity, but higher levels of specificity (average
90%).
• For Enterocheck WB, Enteroscreen, PanBio Multi-test
Dip-S-Tick, Mega Salmonella, SD Bioline,and Onsite Typhoid,
there is insufficient evidence to recommend these tests, as there
are only results from 1, 2, or 3 included studies. Several of these
RDTs had inferior performance to either Typhidot or TUBEX,
based on comparison of sensitivity in the same participants in
single studies.
• We did not find any statistically significant differences in
sensitivity or specificity between Typhidot tests evaluated with
low risk of bias due to clear reporting of indeterminates and the
TUBEX and Test-It Typhoid tests, based on combined data from
both direct and indirect test comparisons (comparisons of test on
either the same patients or different patients).
• Analysis of direct paired (comparative) data was possible
across 10 studies comparing Typhidot and TUBEX, but we did
not find any statistically significant difference between the two
tests. It is not possible to state that one group of index tests has
higher accuracy than another. Within individual studies data was
available to compare other commercial tests, and further studies
are needed to substantiate findings from single studies.
• There was insufficient data to formally investigate sources
of heterogeneity as listed in the ’Secondary objectives’ and
’Investigations of heterogeneity’ sections.
• There were no eligible studies that evaluated RDTs
exclusively for detecting paratyphoid disease.
Strengths and weaknesses of the review
A major problem with most included studies was the use of a rel-
atively weak reference standard. Blood culture has an estimated
sensitivity of between 40% to 80% (WHO 2003), with a more
recent systematic review estimating sensitivity to be around 60%
(Mogasale 2016). Only three studies used the best reference stan-
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dard currently available (blood culture and bone marrow culture).
Bone marrow culture is estimated to increase the number of true
positives by an additional 10% over blood culture alone (WHO
2003; Mogasale 2016). The additional benefit of a blood PCR
result is undefined, and the testing methodology has not yet been
standardized (Smits 2013). A weak reference standard means that
a number of true positive results were classified as false negatives
(Reitsma 2009). There was a great variation in the reporting of
the accreditation and quality of microbiology laboratories where
the cultures were processed.
Statistical analysis of Typhidot and its variants was complicated,
given the evolution of the product target from measuring both
IgM and IgG antibodies to just IgM alone. This was compounded
by the inadequate clarity of the reported results. Many of the in-
cluded studies were not well reported, and did not perform well
under the scrutiny of the modified QUADAS-2 tool. The data for
a number of studies was incomplete, and could not be clarified
despite contacting corresponding authors. Only a few studies re-
ported blinding of the index and reference tests.
A weakness of the review related to the classification and subse-
quent analysis of indeterminate results for Typhidot tests. When
we could extract both IgG and IgMdata for Typhidot, we classified
a case that was IgG positive and IgM negative as indeterminate.
This differed from the treatment of indeterminate results of some
included studies (Fadeel 2011; Olsen 2004).
Thriemer 2013 described the differences in sensitivity and speci-
ficity from one study (Kawano 2007) in three different ways: when
indeterminate results were excluded; when indeterminate results
were considered negative; and when indeterminate results were in-
cluded in the denominator. In our Cochrane Review, this is illus-
trated in Figure 5 and Figure 6. These demonstrate a roughly 20%
decrease in sensitivity when we included indeterminate results in
the analysis. It is important to acknowledge variation in the clas-
sification of indeterminate results as a limitation in the analysis of
results for Typhidot.
Data extraction from certain case control studies, Fadeel 2011,
required careful recalculation where different categories of nega-
tive patients were described, for example, blood culture negative
and Widal Test positive, versus known negatives. Index tests were
then tested against different sub-groups within the cohort. This
change in sampling meant that the prevalence of disease changed
depending on which subgroup the index test was used in.
This review covers both typhoid and paratyphoid fever, but there
were no suitable studies related to paratyphoid alone. Another
weakness of this review was the variability in the treatment of
paratyphoid cases as part of the diagnostic test accuracy data be-
tween studies. In one study, authors excluded cases of blood culture
positive Salmonella Paratyphi A (Jesudason 2006). A number of
studies classified blood culture positive cases of paratyphoid as true
negatives (Gasem 2002; Dutta 2006; Hosamani 2013; Sanjeev
2013). In contrast, paratyphoid fever was classified as a target con-
dition along with typhoid fever in two studies (Dong 2007; Prasad
2015).
Applicability of findings to the review question
A lownumber of studies have evaluated the diagnostic test accuracy
of enteric fever RDTs. Furthermore, the number of good quality
studies was low. The main issues relating to quality include: util-
ity of a second-class reference standard; recruitment of clinically
suspected enteric fever patients as opposed to unselected febrile
patients; poor reporting of whether investigators were blinded to
reference test results when interpreting the index tests; and fre-
quent use of a case control design. The sensitivity and specificity
of TUBEX, Typhidot and its variants, and Test-it Typhoid test
and its KIT protypes are not robust enough to replace existing
diagnostic tools in enteric fever.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The moderate sensitivity and specificity of the evaluated RDTs
does not support their use as a replacement for blood culture for
diagnosing enteric fever. The performance of the RDTs might be
improved by combination with a transparent clinical algorithm
for suspected enteric fever, but such algorithms do not exist. RDTs
can only influence clinical practice if healthcare professionals trust
the result. Although the specificity of the TUBEX and Test-it Ty-
phoid test and KIT prototypes were fairly good, if the RDT de-
livers a negative result in a patient believed to have enteric fever,
the clinician is still likely to prescribe antimicrobials. If a febrile
patient from an endemic region with a positive enteric fever RDT
result also has an alternative febrile illness diagnostic positive (for
example, dengue or malaria RDT) this further complicates man-
agement.
Although this Cochrane Review treated typhoid and paratyphoid
fever as separate target conditions, in clinical practice the distinc-
tion is not clear. Paratyphoid fever is often milder as a clinical
syndrome compared to typhoid (Waddington 2014), although
in some reports the two syndromes have been indistinguishable
(Maskey 2006). In some geographical areas, the levels of multi
drug-resistance in S. Paratyphi A is lower than in S. Typhi, but
nalidixic acid resistance is more common (Darton 2014). Despite
these differences in antimicrobial susceptibility patterns between
typhoid and paratyphoid (McKinnon 2014), an RDT that detects
both typhoid and paratyphoid infections is the most clinically rel-
evant in terms of prompting the commencement of antimicro-
bials. An RDT that distinguishes the two serovars should not alter
management (Andrews 2015).
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Implications for research
The cornerstone of diagnostic test accuracy studies is the reference
standard. Research into developing a better reference standard for
the diagnosis of enteric fever in both adults and children is needed
(Mogasale 2016). This could help the diagnosis of enteric fever in
well-resourced settings, and significantly raise the quality of future
evaluations of RDTs and other diagnostic tests (Reitsma 2009).
The formulation of a composite reference standard for enteric
fever could be one such strategy (Storey 2015). RDTs that detect
both paratyphoid and typhoid fever on the same test are necessary
given the similarities in treatment, and the increasing similarities
in clinical presentation in some settings (Maskey 2006).
Current enteric fever RDTs rely on detecting immuno-serological
responses. Alternative biomarkers of acute enteric fever, such as
metabolomic profiles (Baker 2010; McKinnon 2014), could form
the basis of new groups of RDTs. The unique host genomic sig-
natures during bacterial versus viral infections could also lead to
novel RDTs in the future (Herberg 2016).
Combining anRDTwithin a transparent clinical algorithm for the
febrile patient could potentially improve diagnostic test accuracy.
Further research on combining clinical prediction rules for febrile
illnesses in typhoid endemic with disease-specific RDTs could be a
potential route in a community-based setting (Parry 2011).Quali-
tiative research on how healthcare professionals view RDTs will
be needed to guide larger-scale implementation programmes.
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Point of recruitment: inpatients and outpatients
Patient characteristics and set-
ting
Countries: Indonesia
Level of typhoid endemicity (Crump 2004): high
Age: both adults and children
Gender distribution: not stated
Entry criteria: clinical suspicion of typhoid
Sample size: 425
Index tests Name: latex agglutination assay, Royal Tropical Institute (KIT), Netherlands
Biological sample: venous blood
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Retrospective analysis. Index tests performed on stored serum samples. Time interval not stated
Comparative
Notes The study authors report that two raters evaluated the reproducibility of 123 of the index tests
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
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Abdoel 2007 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Anagha 2012
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: secondary
Point of recruitment: not specified whether inpatient or outpatient
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Age: not specified
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Anagha 2012 (Continued)
Gender distribution: not specified
Entry criteria: fever > 4 days and clinical suspicion of typhoid
Sample size: 83
Index tests Enterocheck WB
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective analysis.Time interval not stated.
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
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Anagha 2012 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Anusha 2011
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary paediatric hospital.
Point of recruitment: not specified whether inpatients or outpatients
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Age: mean age 6.25 years, SD 3.86 years
Gender distribution: male 52% female 48%
Entry criteria: children between 6 months and 18 years of age, and fever ≥ 3 days, and clinical
features of typhoid
Sample size: 450
Index tests Enterocheck WB
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective study.
Comparative
Notes Index tests were used on whole blood or serum, but the study authors did not specify the numbers
of each
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Anusha 2011 (Continued)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
57Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Anusha 2011 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Begum 2009
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: not specified whether inpatient or outpatient
Patient characteristics and set-
ting
Countries: Bangladesh
Level of typhoid endemicity (Crump 2004): high
Age: not specified
Gender distribution: not specified
Entry criteria: clinical suspicion of typhoid fever, and febrile non-typhoid controls, and healthy
controls
Data extraction was based on febrile non-typhoid controls only
Sample size: 100
Index tests Typhidot
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective study. Timing not stated.
Comparative
Notes Healthy (afebrile) controls also recruited.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
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Begum 2009 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
High High
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
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Beig 2010
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: paediatric inpatient
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Age: children (not formally stated)
Gender distribution: not stated
Entry criteria: 6 months to 12 years, and fever > 4 days, and clinical suspicion of typhoid
Sample size: 145
Index tests Typhidot-M
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective study. Timing not stated.
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
High High
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Beig 2010 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Bhutta 1999
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: paediatric inpatients
Patient characteristics and set-
ting
Countries: Pakistan
Level of typhoid endemicity (Crump 2004): high
Age: children (not formally stated)
Gender distribution: male 41% female 49%
Entry criteria: clinical suspicion of typhoid fever
Sample size: 97
Index tests Typhidot and Typhidot-M
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Bhutta 1999 (Continued)
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: Peripheral blood culture and/or bone marrow culture
Flow and timing Prospective study. Timing unclear.
Comparative
Notes Malaysian Biodiagnostic Research (Kuala Lumpur, Malaysia) donated rapid diagnostic tests (RDTs)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Bhutta 1999 (Continued)
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Yes
Low
Dong 2007
Study characteristics Study characteristics
Patient sampling Prospective multicentre study as part of a vaccine surveillance programme
Healthcare settings: primary, secondary, and tertiary centres (85 in total)
Point of recruitment: inpatient and outpatient
Patient characteristics and set-
ting
Countries: China
Level of typhoid endemicity (Crump 2004): medium
Age: not specified
Gender distribution: not specified
Entry criteria: aged between 5 and 60 years with a history of fever ≥ 3 days
Sample size: 1874
Index tests Typhidot-M
TUBEX
Target condition and reference
standard(s)
Target condition: both Salmonella Typhi and Salmonella Paratyphi A
Reference standard: peripheral blood culture (8 mL)
Flow and timing Prospective multicentre study as part of a vaccine surveillance programme. Index tests performed
in real time during patient recruitment
Comparative
Notes Reported diagnostic test accuracy for detecting cases of Salmonella Paratyphi A as well as Salmonella
Typhi.
Methodological quality Methodological
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Dong 2007 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Dong 2007 (Continued)
Were all patients included in the
analysis?
No
Low
Dutta 2006
Study characteristics Study characteristics
Patient sampling Prospective multicentre study as part of a community-based typhoid surveillance study and mass
vaccination programme
Healthcare setting: primary, secondary, and tertiary (7 health outposts in total)
Point of recruitment: inpatient and outpatient
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Age: not specified
Gender distribution: not specified
Entry criteria: fever ≥ 3 days
Sample size: 6697 plus 172 healthy controls.
Only a subset of participants had TUBEX or Typhidot testing.
Control participants for 2x2 were based on febrile participants and did not include healthy controls
Index tests TUBEX
Typhidot
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Community-based typhoid surveillance study and mass vaccination programme. Timing of sample
testing unclear
Comparative
Notes Not all patients received the same index test.
If Salmonella Paratyphi was isolated, study authors classified this as a true negative
If a participant was both blood culture-positive andmalaria film-positive, the study authors excluded
them from the analysis (n = 1). Study authors only included a small number or participants in the
analysis
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
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Dutta 2006 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
High High
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
High
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Fadeel 2011
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: secondary and tertiary (5 fever hospitals)
Point of recruitment: inpatients
Patient characteristics and set-
ting
Countries: Egypt
Level of typhoid endemicity (Crump 2004): medium
Age: over the age of 4 years
Gender distribution: not stated
Entry criteria: fever lasting for at least 2 days, or febrile ≥ 38.5°C on admission, with a clinical
suspicion of typhoid fever or brucellosis
Sample size: 2897
Index tests TUBEX
Typhidot-M
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standards: peripheral blood culture
Flow and timing Divided into 3 main groups of ’typhoid’ (cases), ’febrile non-typhoid’ (controls), and healthy con-
trols. Timing unclear
Comparative
Notes Case: control design.
Excluded febrile cases of diarrhoea and pneumonia.
Study authors classified a Widal Test titre of > 320 as a typhoid case
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
No
High High
DOMAIN 2: Index Test All tests DOMAIN 2: Index
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Fadeel 2011 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
Gasem 2002
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: secondary (3) and tertiary (1)
Point of recruitment: inpatient
Patient characteristics and set-
ting
Countries: Indonesia
Level of typhoid endemicity (Crump 2004): high
Age: not stated
Gender distribution: not stated
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Gasem 2002 (Continued)
Entry criteria: clinical suspicion of typhoid (127) and 80 febrile ’non-typhoids’
Sample size: 207
Index tests Dipstick assay from the Royal Tropical Institute, Netherlands (KIT)
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standards: peripheral blood culture or bone marrow culture, or both
Flow and timing Prospective multi-centre study. Timing unclear.
Comparative
Notes Not all patients had both bone marrow culture and blood culture
Study authors classified Isolation of Salmonella Paratyphi as a non-typhoid case.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Gasem 2002 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
Gopalakrishnan 2002
Study characteristics Study characteristics
Patient sampling Retrospective single-centre study
Healthcare setting: tertiary
Point of recruitment: not specified whether inpatient or outpatient
Patient characteristics and set-
ting
Countries: Malaysia
Level of typhoid endemicity (Crump 2004): medium
Age: not specified
Gender distribution: not specified
Entry criteria: Widal test titres greater than 640
Sample size: 144
Index tests Typhidot
PanBio
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standards: peripheral blood culture or stool culture, or both
Flow and timing Retrospective analysis of stored samples. Timing unclear.
Comparative
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Gopalakrishnan 2002 (Continued)
Notes Inclusion criteria based on Widal Test titres - limiting.
Reference standard included isolation of Salmonella Typhi from stool
Index tests were performed retrospectively on stored samples
Typhidot-M performed on only small subset of samples.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
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Gopalakrishnan 2002 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Low
Hatta 2002a
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: primary, secondary, and tertiary
Point of recruitment: inpatient and outpatient
Patient characteristics and set-
ting
Countries: Indonesia and Kenya
Level of typhoid endemicity (Crump 2004): high
Age: not specified
Gender distribution: not specified
Entry criteria: clinical suspicion of typhoid, and other febrile illnesses (controls), and healthy afebrile
controls
Sample size: 504
Index tests Dipstick Assay, Royal Tropical Institute (KIT), Netherlands
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective recruitment at multiple sites. Timing unclear.
Comparative
Notes Case-control study design from 2 geographical locations, including controls from a non-endemic
area (Netherlands)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
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Hatta 2002a (Continued)
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Yes
Low
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Hatta 2002b
Study characteristics Study characteristics
Patient sampling Propspective multicentre study
Healthcare setting: Primary, secondary, and tertiary
Point of recruitment: inpatient and outpatient
Patient characteristics and set-
ting
Countries: Indonesia
Level of typhoid endemicity (Crump 2004): high
Age: not specified
Gender distribution: not specified
Entry criteria: clinical suspicion of typhoid
Sample size: 473
Index tests Dipstick assay, Royal Tropical Institute (KIT) Netherlands
Target condition and reference
standard(s)
Target condition:Salmonella Typhi
Reference standard: peripheral blood culture (5 mL)
Flow and timing Prospective multi-centre study. Timing unclear.
Comparative
Notes There is a potential overlap of patients/data between the paper by Hatta 2002a.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Hatta 2002b (Continued)
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Hosamani 2013
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: not stated
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Age: mixed
Gender distribution: 58% Male 42% Female
Entry criteria: history of fever more than 2 to 3 days duration and a clinical diagnosis of enteric
fever
Index tests Typhidot
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Hosamani 2013 (Continued)
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (volume not stated)
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes No sources of funding declared.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Hosamani 2013 (Continued)
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
High
House 2001
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: secondary and tertiary
Point of recruitment: inpatients
Patient characteristics and set-
ting
Countries: Vietnam
Level of typhoid endemicity (Crump 2004): high
Age: adults and children
Gender distribution: not specified
Entry criteria: Salmonella Typhi on blood culture, and febrile controls, and healthy controls
Sample size: 290
Index tests TUBEX
Dipstick Assay, Royal Tropical Institute (KIT), Netherlands
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective multicentre study. Timing unclear.
Comparative
Notes Mostly children recruited. Sample size 290 but only 127 analysed. Case control design
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
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House 2001 (Continued)
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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House 2001 (Continued)
Low
Islam 2016
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary international reference centre
Point of recruitment: not stated
Patient characteristics and set-
ting
Countries: Bangladesh
Level of typhoid endemicity (Crump 2004): high
Age: mixed
Gender distribution: 52% male 48% female
Entry criteria: non-pregnant, 1 to 59 years of age, fever ≥ 39.0°C for 3 to 7 days duration, lacking
obvious alternative diagnosis
Index tests TUBEX
Typhidot
TPTest
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (3 to 5 mL)
Flow and timing Prospective study at a tertiary reference centre. Timing unclear
Comparative
Notes Unable to clarify whether patients in Group VI (visceral leishmaniasis/tuberculosis) also received a
blood culture
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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Islam 2016 (Continued)
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Low
Ismail 2002
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: tertiary (5 infectious diseases hospitals)
Point of recruitment: inpatients
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Ismail 2002 (Continued)
Patient characteristics and set-
ting
Countries: Egypt
Level of typhoid endemicity (Crump 2004): medium
Age: not specified
Gender distribution: not specified
Entry criteria: febrile in-patients meeting pre-determined case definitions
Sample size: 85
Index tests Dipstick assay, Royal Tropical Institute (KIT), Netherlands
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective multicentre study. Samples tested retrospectively 2 to 3 months after recruitment
Comparative
Notes Part of a brucellosis diagnostic study.
Samples tested retrospectively 2 to 3 months later.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
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Ismail 2002 (Continued)
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Jesudason 2002
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Tertiary healthcare setting
Point of recruitment: unclear whether inpatient, outpatient, or both
Patient characteristics and set-
ting
Country: India
Level of typhoid endemicity (Crump 2004): high
Age(s): unclear
Gender distribution: unclear
Four pre-determined groups for entry into the study:
1. Salmonella Typhi blood culture positive;
2. Non-Typhi Gram-negative bacilli culture positive;
3. Widal Test positive; and
4. Widal Test negative.
Sample size: 150 recruited (60 analysed)
Index tests Typhidot
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Jesudason 2002 (Continued)
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes Indian Association Medical Microbiology External Quality Assurance Scheme laboratory accredi-
tation
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
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Jesudason 2002 (Continued)
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
Jesudason 2006
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: both inpatients and outpatients
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Ages: unclear
Gender distribution: unclear
Entry criteria: clinical suspicion of typhoid fever
Sample size: 563
Index tests Typhidot
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes Study authors excluded one case of Salmonella paratyphi A.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
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Jesudason 2006 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
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Kawano 2007
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary infectious diseases hospital
Point of recruitment: inpatients
Patient characteristics and set-
ting
Countries: Philippines
Level of typhoid endemicity (Crump 2004): high
Age: both adults and children
Gender distribution: 53.6% (male) 46.4% (female)
Entry criteria: febrile patients with a clinical suspicion of typhoid fever
Sample size: 177
Index tests TUBEX
Typhidot
SD Bioline
Mega Salmonella
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Yes
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Kawano 2007 (Continued)
dard?
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Keddy 2011
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: secondary and tertiary hospitals
Point of recruitment: inpatient
Patient characteristics and set-
ting
Countries: South Africa and Tanzania
Level of typhoid endemicity (Crump 2004): medium
Age: both adults and children
Gender distribution: 54.3% (male) 45.7% (female)
Entry criteria:
South Africa - clinically suspected typhoid fever with no pre-treatment with antibiotics
Tanzania - unselected febrile illnesses, but only those with clinical suspicion of typhoid fever were
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Keddy 2011 (Continued)
recruited
Sample size: 92
Index tests TUBEX
Typhidot
Target condition and reference
standard(s)
Target condition:Salmonella Typhi
Reference standard: peripheral blood culture
Flow and timing Prospective multicentre study
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
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Keddy 2011 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Khan 2002
Study characteristics Study characteristics
Patient sampling Retrospective single centre study
Healthcare setting: tertiary hospital
Point of recruitment: both inpatient and outpatient
Patient characteristics and set-
ting
Countries: Pakistan
Level of typhoid endemicity (Crump 2004): high
Age: unclear
Gender distribution: unclear
Entry criteria: patients with clinical suspicion of typhoid who went on to have the index RDT
Sample size: 1760 (128 analysed)
Index tests Typhidot-M
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard: peripheral blood culture, or bone marrow culture, or both
Flow and timing Retrospective analysis on stored samples. Timing unclear.
Comparative
Notes Unable to distinguish which cases were bone marrow positive.
Methodological quality Methodological
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Khan 2002 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
No
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Khan 2002 (Continued)
Were all patients included in the
analysis?
No
High
Khanna 2015
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: unclear
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Age: mixed
Gender distribution: not stated
Entry criteria: cases were febrile patients with a positive blood culture for Salmonella Typhi. Healthy
afebrile controls
Index tests TUBEX
Typhidot
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (5 mL)
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes Case control study
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
No
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Khanna 2015 (Continued)
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Khoharo 2011
Study characteristics Study characteristics
Patient sampling Prospective single-centre study
Healthcare setting: tertiary
Point of recruitment: not stated
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Khoharo 2011 (Continued)
Patient characteristics and set-
ting
Countries: Pakistan
Level of typhoid endemicity (Crump 2004): high
Age: adults (> 18 years)
Gender distribution: not stated
Entry criteria: aged 18 to 40 years; fever < 14 days; clinical features suggesting typhoid fever; no
history of antimicrobial therapy or typhoid immunization in the recent past
Index tests Typhidot
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (volume not stated)
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes No declaration of funding. Entry criteria could exclude numerous cases of typhoid
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
No
High High
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
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Khoharo 2011 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Ley 2011
Study characteristics Study characteristics
Patient sampling Retrospective multi-centre study
Healthcare settings: secondary
Point of recruitment: both inpatient and outpatient
Patient characteristics and set-
ting
Countries: Tanzania
Level of typhoid endemicity (Crump 2004): medium
Age: children between the ages of 2 months and 14 years
Gender distribution: unclear
Entry criteria: selected samples from a fever surveillance study
Surveillance study entry criteria: fever > 3 days or those matching set clinical severity criteria
Index tests TUBEX
Target condition and reference
standard(s)
Target condition:Salmonella Typhi
Reference standard(s): peripheral blood culture
Flow and timing Retrospective analysis on stored samples. Timing unclear.
Comparative
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Ley 2011 (Continued)
Notes Only blood culture positive patients included. Samples from 2 different patient populations
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Ley 2011 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
Limpitikul 2014
Study characteristics Study characteristics
Patient sampling Prospective multicentre study (3 hospitals within a single province)
Healthcare setting: secondary
Point of recruitment: both inpatients and outpatients
Patient characteristics and set-
ting
Countries: Thailand
Level of typhoid endemicity (Crump 2004): high
Age: children under 15 years of age
Gender distribution: not recorded
Entry criteria: any febrile illness in children under 15 years of age
Index tests SD Bioline
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (volume not stated)
Flow and timing Prospective recruitment with a retrospective analysis of stored samples
Comparative
Notes Outbreak situation in Songkhla Province.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Limpitikul 2014 (Continued)
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
Maude 2015
Study characteristics Study characteristics
Patient sampling Prospective single-centre study
Healthcare setting: tertiary
Point of recruitment: inpatient
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Maude 2015 (Continued)
Patient characteristics and set-
ting
Countries: Bangladesh
Level of typhoid endemicity (Crump 2004): high
Age: mixed
Gender distribution: 173 males; 127 females
Entry criteria: > 6 months of age with < 2 weeks fever and a documented fever > 38
Index tests Test-It-Typhoid (KIT immunochromatographic lateral flow assay)
SD Bioline
CTK Biotech Onsite
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (1 to 12 mL in children, 5 to 12mL in adults) or
blood nucleic acid amplification (polymerase chain reaction (PCR)), or both
Flow and timing Prospective recruitment with retrospective testing of stored samples
Comparative
Notes Two review authors (LW and CMP) are authors on this study.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
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Maude 2015 (Continued)
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
Mehmood 2015
Study characteristics Study characteristics
Patient sampling Retrospective single centre analysis study
Healthcare setting: tertiary
Point of recruitment: not stated
Patient characteristics and set-
ting
Countries: Pakistan
Level of typhoid endemicity (Crump 2004): high
Age: mixed
Gender distribution: 59 males/86 females
Entry criteria: unselected fever of greater than 3 days
Index tests Typhidot
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (volume not specified)
Flow and timing Retrospective analysis of stored samples. Timing unclear.
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Mehmood 2015 (Continued)
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
No
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
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Mehmood 2015 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Moore 2014
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: inpatient
Patient characteristics and set-
ting
Countries: Cambodia
Level of typhoid endemicity (Crump 2004): high
Age: children over 6 months and under 16 years
Gender distribution: unclear
Entry criteria: documented fever of > 38°C
Sample size: 500
Index tests Immunochromatographic lateral flow assay, KIT (Test-It-Typhoid prototype)
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture
Flow and timing Prospective single centre study. Retrospective testing of stored samples
Comparative
Notes Score of 2+ or more considered positive. We contacted the study authors for further details based
on the abstract
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
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Moore 2014 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
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Naheed 2008
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: primary community clinics
Point of recruitment: outpatients
Patient characteristics and set-
ting
Countries: Bangladesh
Level of typhoid endemicity (Crump 2004): high
Age: both adults and children
Gender distribution: 51% (male) 49% (female)
Entry criteria: fever for any duration in < 5 years / > 3 days in > 5years and a documented fever of
38.0°C
Sample size: 867
Index tests TUBEX
Typhidot
Target condition and reference
standard(s)
Target condition:Salmonella Typhi
Reference standard(s): peripheral blood culture
Flow and timing Prospective multicentre study. Timing unclear.
Comparative
Notes Study authors classified 139 results that were indeterminate as negative
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
103Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Naheed 2008 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Olsen 2004
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: secondary and tertiary
Point of recruitment: inpatients
Patient characteristics and set-
ting
Countries: Vietnam
Level of typhoid endemicity (Crump 2004): high
Age: both adults and children
Gender distribution: 56.9% (male) 43.1% (female)
Entry criteria: > 4 days of fever, and greater than 3 years old and controls with other febrile illnesses
Sample size: 79 (59 patients and 20 controls)
104Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Olsen 2004 (Continued)
Index tests TUBEX
Typhidot
Multi-Test Dip-S-Tick
Target condition and reference
standard(s)
Target condition:Salmonella Typhi
Reference standard(s): peripheral blood culture
Flow and timing Prospective multicentre study. Samples processed at a different site. Timing unclear
Comparative
Notes Different processing sites for blood culture, that is not in the same laboratory
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
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Olsen 2004 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
Pastoor 2008
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: inpatient
Patient characteristics and set-
ting
Countries: Indonesia
Level of typhoid endemicity (Crump 2004): high
Age: unclear
Gender distribution: unclear
Entry criteria: clinical suspicion of typhoid fever
Sample size: 209
Index tests Immunochromatographic lateral flow assay, Royal Tropical Institute (KIT), Netherlands
Target condition and reference
standard(s)
Target condition:Salmonella Typhi
Reference standard(s): peripheral blood culture and Widal Test
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes Study authors compared diagnostic test results of the ICT with both blood culture and the Widal
Test
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Pastoor 2008 (Continued)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Pastoor 2008 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Prasad 2015
Study characteristics Study characteristics
Patient sampling Single centre retrospective analysis study
Healthcare setting: tertiary
Point of recruitment: both inpatients and outpatients
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Age: unclear
Gender distribution: unclear
Entry criteria: clinical suspicion of enteric fever
Index tests Typhidot-M
Enteroscreen-IgM
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (volume not stated)
Flow and timing Retrospective analysis of stored samples. Timing unclear.
Comparative
Notes Study authors classified Salmonella Paratyphi blood culture positive cases as disease-negative.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
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Prasad 2015 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
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Rahman 2007
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: outpatients
Patient characteristics and set-
ting
Countries: Bangladesh
Level of typhoid endemicity (Crump 2004): high
Age: children
Gender distribution: unclear
Entry criteria: fever > 3 days but < 7 days
Sample size: 243
Index tests TUBEX
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Rahman 2007 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Sanjeev 2013
Study characteristics Study characteristics
Patient sampling Prospective single centre study
Healthcare setting: tertiary
Point of recruitment: not stated
Patient characteristics and set-
ting
Countries: India
Level of typhoid endemicity (Crump 2004): high
Age: not clear
Gender distribution: not stated
Entry criteria: clinical suspicion of typhoid fever
Index tests Typhidot
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Sanjeev 2013 (Continued)
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (volume not specified)
Flow and timing Prospective single centre study. Timing unclear.
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
No
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Unclear
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Sanjeev 2013 (Continued)
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Siba 2012
Study characteristics Study characteristics
Patient sampling Prospective multicentre study
Healthcare setting: secondary and tertiary hospitals
Point of recruitment: outpatients
Patient characteristics and set-
ting
Country: Papua New Guinea
Level of typhoid endemicity (Crump 2004): high
Age: adults and children
Gender distribution: 51% (male) 49% (female)
Entry criteria: febrile patients with axillary temp > 37.5°C and > 2 days of fever (or clinical suspicion
of typhoid fever)
Sample size: 530 (500 analysed)
Index tests TUBEX
Typhidot
TyphiRapid-Tr02
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture and PCR
Flow and timing Prospective multicentre study. Timing unclear.
Comparative
Notes
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
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Siba 2012 (Continued)
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Siba 2012 (Continued)
Low
Tarupiwa 2015
Study characteristics Study characteristics
Patient sampling Prospective multi-centre study
Healthcare setting: primary
Point of recruitment: outpatient
Patient characteristics and set-
ting
Countries: Zimbabwe
Level of typhoid endemicity (Crump 2004): medium
Age: mixed
Gender distribution: not stated
Entry criteria: ’typical signs and symptoms of typhoid’
Index tests TUBEX
On-Site Typhoid IgG/IgM Combo
Target condition and reference
standard(s)
Target condition: Salmonella Typhi
Reference standard(s): peripheral blood culture (3 to 5 mL)
Flow and timing Prospective multicentre study. Timing unclear.
Comparative
Notes Diagnostic test accuracy data not provided in published paper but supplied separately by the corre-
sponding authors
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests DOMAIN 2: Index
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Tarupiwa 2015 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Low
Abbreviations: PCR: polymerase chain reaction; RDT: rapid diagnostic test.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alejandria 2012 Meta-analysis from an International Congress on Infectious Diseases (ICID) poster abstract
Bakr 2011 4 different types of Widal Test used, that is, not a new rapid diagnostic test (RDT)
Banchuin 1987 Antigen detection was neither a commercially-available rapid diagnostic test or a prototype
Banerjee 1984 We were unable to extract specificity and sensitivity data
Boomsma 1988 We were unable to extract sensitivity and specificity data
Cardona-Castro 2000 Not a commercially available test (’Dot Blot’ Test from Bio-Rad Laboratories, Richmond, CA)
Castonguay-Vanier 2013 We could only extract data for patients with Gram-negative rod positive blood cultures. The study authors
did not present data on RDT performance on culture negative patients, therefore we could not perform
analyses
Chaicumpa 1992 Not a commercially available test (an unspecified Indirect dot blot ELISA)
Chart 2007 Not a commercially available RDT. A range of Salmonella serodiagnostic tests were performed at a UK
reference laboratory on sera from UK residents returning from travelling abroad
Chatterjee 1988 Not a commercially available test. “COAG” co-agglutination test produced in-house by Indian tertiary
hospital laboratory
Choo 1994 We were unable to extract data about performance of test in blood culture positive patients. DOT EIA
(early Typhidot-M)
Choo 1997 We were unable to extract relevant sensitivity and specificity data. DOT-EIA (early Typhidot-M)
Chua 2012 Evaluates a test for detecting chronic carriage rather than acute typhoid (enteric) fever
Coovadia 1986 Not a commercially available test (passive haemagglutination)
Das 2013 Not a commercially available test - candidate created by SPAN Diagnostics (India)
Dhanalakshmi 1986 We were unable to determine which blood culture positive patients were also positive on the urinary
COAG tests
el-Falaky 1970 We were unable to extract sensitivity and specificity data as no cut-offs mentioned for haemagglutination
Fadeel 2004 Not a commercial test: ELISA antibody detection from urine
Felezsko 2004 Letter outlining use of TUBEX to detect non-typoidal Salmonella infections (e.g. S. enteritidis)
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(Continued)
Gorelov 1988 Comparison of two types of Widal Test
Handojo 2004 Evaluation of a Widal slide agglutination test, a variant of an existing diagnostic test
Hoffman 1986 Evaluation of a slide agglutination Widal Test
House 2005 Paired serum samples rather than a single use RDT
Jackson 1995 Dot Enzyme Immmunoassay (EIA) - early Typhidot-M.Wewere unable to extract sensitivity or specificity
data
John 1984 Not a commercial test: passive bacterial agglutination
Kalhan 1998 Not a commercial test: reverse passive haemagglutination assay (possible RDT candidate)
Kalhan 1999 Not a commercial test: Latex Agglutination Test
Kariuki 2004 No actual RDT evaluated. Study compared blood culture with the Widal Test
Kaur 1988a Not commercially-available rapid diagnostic tests. In-house latex agglutination (LAT) and coagglutination
(COAG) tests which are not prototypes
Kaur 1988b The serodiagnostic tests evaluated were not commercially available point-of-care tests
Khanam 2013 The TPTest is not a commercially-available RDT
Khanam 2015 The study detailed the assessment of the human immune response rather than diagnostic test accuracy
Kollaritsch 1988 Letter to the editor about a single case - not a diagnostic study
Korbsrisate 1998 Not a commercial test: Indirect ELISA IgM antibody detection
Kuchuloria 2016 No commercial RDTs were used in the febrile illness study, only laboratory serology for Salmonella Typhi
Lim 1998 Reference standard inadequately described, and not all patients received any form of reference standard.
TUBEX
Lutterloh 2012 Use of TUBEX to determine cases as part of active surveillance during an outbreak. We were unable to
extract any data regarding diagnostic test accuracy
Malik 2001 No data of index test (Typhidot) positivity in non-culture positive patients
Mukherjee 1993 Not a commercial test. In-house co-agglutination test
Munir 2015 This study only included clinical typhoid or conifrmed typhoid cases. Study authors excluded patients
currently receiving or who had recently received antimicrobials. We were unable to extract data related
to diagnostic test accuracy
118Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
(Continued)
Narayanappa 2010 We were unable to extract data index test data (Typhidot-M) from control (non-typhoid fever) group
Neil 2012 Variety of serological diagnostic tests used during investigation of an acute outbreak in Uganda. No
specific RDT used
Nguyen 1997 The monoclonal antibody-based dot-blot ELISA evaluated is not a commercially-available rapid diag-
nostic test
Ong 1989 Test based on adherence IgM “capture” - not commercially available
Confirmed typhoid case was blood or stool culture positive, or both
Pandya 1995 Not a commercially available RDT: latex agglutination to a) Typhi Vi; and b) Barber protein
Petchclai 1987 Not a commercial test: passive haemagglutination test (PHA)
We were unable to extract sensitivity and specificity data
Peterson 2010 Evaluation of general bacterial microarray/genetics rather than point-of-care testing
Preechakasedkit 2012 RDT development rather than evaluation of test accuracy
Rai 1989 Non-commercial tests. We were unable to extract sensitivity and specificity data
Shrivastava 2011 Repeat publication of data published by Olsen 2004 from Vietnam.
Surachmanto 2011 TUBEX in asthmatics. We were unable to extract diagnostic test data
Tantivanich 1984 Not a commercial test: latex agglutination.
Thevanesam 1992 Widal Test evaluation, not a commercial RDT
Watt 2005 We were unable to extract sensitivity and specificity data
West 1989 Not a commercial test: urinary co-agglutination technique
Wijedoru 2012 Data from this study had already been included in Moore 2014
Yan 2011 We were unable to extract specificity data
Zaka-ur-Rab 2012 Not a commercial test: Salivary IgA to lipopolysaccharide (LPS)
Abbreviations: RDT: rapid diagnostic test.
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 Typhidot. Antibody: IgM or as
reported. 1 result per study
17 3691
2 Typhidot. Antibody: IgM or as
reported. Reference: BC
15 3466
3 Typhidot. Antibody: IgM or as
reported. Reference: BC and
BM
2 225
4 Typhidot. Antibody: IgM or as
reported. Reference: BC and
PCR
1 500
5 Typhidot. Antibody: IgM or
as reported. Indeterminates
reported
6 1721
6 Typhidot. Antibody: IgM or as
reported. Indeterminates not
reported
11 1970
7 Typhidot-M. Antibody: IgM 6 3334
8 Typhi rapid Tr-02. Reference:
BC. Antibody: IgM
1 500
9 Typhi rapid Tr-02. Reference:
BC & PCR. Antibody: IgM
1 500
10 Typhidot all tests 1 result per
study
22 6928
11 TUBEX. Reference:BC 14 4885
12 TUBEX. Reference: BC &
PCR
1 500
13 TUBEX 1 result per study 14 4885
14 KIT ICT. Reference:BC.
Threshold > 1+
2 709
15 KIT ICT. Reference: BC &
PCR. Threshold > 1+
2 800
16 KIT latex agglutination.
Threshold > 1+
1 425
17 KIT Dipstick. Threshold > 1+ 5 1394
18 KIT ICT. Threshold > 1+ 3 1009
19 KIT all tests. Threshold > 1+.
One result per study.
9 2828
20 KIT all tests. Threshold > 2+
studies only
5 1607
21 Enterocheck WB 2 533
22 PanBio 1 144
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23 SD Bioline. Antibody: IgG 3 1669
24 SD Bioline. Antibody: IgM 3 1590
25 SD Bioline Antibody: IgM and
IgG
1 300
26 Mega Salmonella. Antibody:
IgG
1 177
27 Mega Salmonella. Antibody:
IgM
1 177
28 Multi-Test Dip-S-Tick 1 75
29 Enteroscreen 1 1521
30 Onsite Typhoid Combo CTK
Biotech
2 436
Test 1. Typhidot. Antibody: IgM or as reported. 1 result per study.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 1 Typhidot. Antibody: IgM or as reported. 1 result per study
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bhutta 1999 43 13 3 38 0.93 [ 0.82, 0.99 ] 0.75 [ 0.60, 0.86 ]
Fadeel 2011 42 5 25 309 0.63 [ 0.50, 0.74 ] 0.98 [ 0.96, 0.99 ]
Gopalakrishnan 2002 41 30 9 64 0.82 [ 0.69, 0.91 ] 0.68 [ 0.58, 0.77 ]
Hosamani 2013 4 24 0 72 1.00 [ 0.40, 1.00 ] 0.75 [ 0.65, 0.83 ]
Islam 2016 18 25 10 54 0.64 [ 0.44, 0.81 ] 0.68 [ 0.57, 0.78 ]
Jesudason 2002 30 6 0 24 1.00 [ 0.88, 1.00 ] 0.80 [ 0.61, 0.92 ]
Jesudason 2006 36 6 3 500 0.92 [ 0.79, 0.98 ] 0.99 [ 0.97, 1.00 ]
Kawano 2007 41 36 34 66 0.55 [ 0.43, 0.66 ] 0.65 [ 0.55, 0.74 ]
Keddy 2011 17 25 10 39 0.63 [ 0.42, 0.81 ] 0.61 [ 0.48, 0.73 ]
Khan 2002 49 26 20 33 0.71 [ 0.59, 0.81 ] 0.56 [ 0.42, 0.69 ]
Khanna 2015 36 5 14 45 0.72 [ 0.58, 0.84 ] 0.90 [ 0.78, 0.97 ]
Khoharo 2011 72 2 2 46 0.97 [ 0.91, 1.00 ] 0.96 [ 0.86, 0.99 ]
Mehmood 2015 4 50 11 80 0.27 [ 0.08, 0.55 ] 0.62 [ 0.53, 0.70 ]
Naheed 2008 29 197 14 627 0.67 [ 0.51, 0.81 ] 0.76 [ 0.73, 0.79 ]
Olsen 2004 46 2 12 17 0.79 [ 0.67, 0.89 ] 0.89 [ 0.67, 0.99 ]
Sanjeev 2013 30 7 0 13 1.00 [ 0.88, 1.00 ] 0.65 [ 0.41, 0.85 ]
Siba 2012 21 100 1 378 0.95 [ 0.77, 1.00 ] 0.79 [ 0.75, 0.83 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 2. Typhidot. Antibody: IgM or as reported. Reference: BC.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 2 Typhidot. Antibody: IgM or as reported. Reference: BC
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Fadeel 2011 42 5 25 309 0.63 [ 0.50, 0.74 ] 0.98 [ 0.96, 0.99 ]
Gopalakrishnan 2002 41 30 9 64 0.82 [ 0.69, 0.91 ] 0.68 [ 0.58, 0.77 ]
Hosamani 2013 4 24 0 72 1.00 [ 0.40, 1.00 ] 0.75 [ 0.65, 0.83 ]
Islam 2016 18 25 10 54 0.64 [ 0.44, 0.81 ] 0.68 [ 0.57, 0.78 ]
Jesudason 2002 30 6 0 24 1.00 [ 0.88, 1.00 ] 0.80 [ 0.61, 0.92 ]
Jesudason 2006 36 6 3 500 0.92 [ 0.79, 0.98 ] 0.99 [ 0.97, 1.00 ]
Kawano 2007 41 36 34 66 0.55 [ 0.43, 0.66 ] 0.65 [ 0.55, 0.74 ]
Keddy 2011 17 25 10 39 0.63 [ 0.42, 0.81 ] 0.61 [ 0.48, 0.73 ]
Khanna 2015 36 5 14 45 0.72 [ 0.58, 0.84 ] 0.90 [ 0.78, 0.97 ]
Khoharo 2011 72 2 2 46 0.97 [ 0.91, 1.00 ] 0.96 [ 0.86, 0.99 ]
Mehmood 2015 4 50 11 80 0.27 [ 0.08, 0.55 ] 0.62 [ 0.53, 0.70 ]
Naheed 2008 29 197 14 627 0.67 [ 0.51, 0.81 ] 0.76 [ 0.73, 0.79 ]
Olsen 2004 46 2 12 17 0.79 [ 0.67, 0.89 ] 0.89 [ 0.67, 0.99 ]
Sanjeev 2013 30 7 0 13 1.00 [ 0.88, 1.00 ] 0.65 [ 0.41, 0.85 ]
Siba 2012 21 100 1 378 0.95 [ 0.77, 1.00 ] 0.79 [ 0.75, 0.83 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 3. Typhidot. Antibody: IgM or as reported. Reference: BC and BM.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 3 Typhidot. Antibody: IgM or as reported. Reference: BC and BM
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bhutta 1999 43 13 3 38 0.93 [ 0.82, 0.99 ] 0.75 [ 0.60, 0.86 ]
Khan 2002 49 26 20 33 0.71 [ 0.59, 0.81 ] 0.56 [ 0.42, 0.69 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 4. Typhidot. Antibody: IgM or as reported. Reference: BC and PCR.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 4 Typhidot. Antibody: IgM or as reported. Reference: BC and PCR
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Siba 2012 33 88 14 365 0.70 [ 0.55, 0.83 ] 0.81 [ 0.77, 0.84 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 5. Typhidot. Antibody: IgM or as reported. Indeterminates reported.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 5 Typhidot. Antibody: IgM or as reported. Indeterminates reported
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Fadeel 2011 42 5 25 309 0.63 [ 0.50, 0.74 ] 0.98 [ 0.96, 0.99 ]
Kawano 2007 41 36 34 66 0.55 [ 0.43, 0.66 ] 0.65 [ 0.55, 0.74 ]
Keddy 2011 17 25 10 39 0.63 [ 0.42, 0.81 ] 0.61 [ 0.48, 0.73 ]
Khan 2002 49 26 20 33 0.71 [ 0.59, 0.81 ] 0.56 [ 0.42, 0.69 ]
Naheed 2008 29 197 14 627 0.67 [ 0.51, 0.81 ] 0.76 [ 0.73, 0.79 ]
Olsen 2004 46 2 12 17 0.79 [ 0.67, 0.89 ] 0.89 [ 0.67, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 6. Typhidot. Antibody: IgM or as reported. Indeterminates not reported.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 6 Typhidot. Antibody: IgM or as reported. Indeterminates not reported
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bhutta 1999 43 13 3 38 0.93 [ 0.82, 0.99 ] 0.75 [ 0.60, 0.86 ]
Gopalakrishnan 2002 41 30 9 64 0.82 [ 0.69, 0.91 ] 0.68 [ 0.58, 0.77 ]
Hosamani 2013 4 24 0 72 1.00 [ 0.40, 1.00 ] 0.75 [ 0.65, 0.83 ]
Islam 2016 18 25 10 54 0.64 [ 0.44, 0.81 ] 0.68 [ 0.57, 0.78 ]
Jesudason 2002 30 6 0 24 1.00 [ 0.88, 1.00 ] 0.80 [ 0.61, 0.92 ]
Jesudason 2006 36 6 3 500 0.92 [ 0.79, 0.98 ] 0.99 [ 0.97, 1.00 ]
Khanna 2015 36 5 14 45 0.72 [ 0.58, 0.84 ] 0.90 [ 0.78, 0.97 ]
Khoharo 2011 72 2 2 46 0.97 [ 0.91, 1.00 ] 0.96 [ 0.86, 0.99 ]
Mehmood 2015 4 50 11 80 0.27 [ 0.08, 0.55 ] 0.62 [ 0.53, 0.70 ]
Sanjeev 2013 30 7 0 13 1.00 [ 0.88, 1.00 ] 0.65 [ 0.41, 0.85 ]
Siba 2012 21 100 1 378 0.95 [ 0.77, 1.00 ] 0.79 [ 0.75, 0.83 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 7. Typhidot-M. Antibody: IgM.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 7 Typhidot-M. Antibody: IgM
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Begum 2009 13 23 1 18 0.93 [ 0.66, 1.00 ] 0.44 [ 0.28, 0.60 ]
Beig 2010 27 71 3 44 0.90 [ 0.73, 0.98 ] 0.38 [ 0.29, 0.48 ]
Bhutta 1999 39 16 7 35 0.85 [ 0.71, 0.94 ] 0.69 [ 0.54, 0.81 ]
Dong 2007 7 148 6 1571 0.54 [ 0.25, 0.81 ] 0.91 [ 0.90, 0.93 ]
Dutta 2006 41 7 46 33 0.47 [ 0.36, 0.58 ] 0.83 [ 0.67, 0.93 ]
Prasad 2015 108 319 3 748 0.97 [ 0.92, 0.99 ] 0.70 [ 0.67, 0.73 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 8. Typhi rapid Tr-02. Reference: BC. Antibody: IgM.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 8 Typhi rapid Tr-02. Reference: BC. Antibody: IgM
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Siba 2012 22 88 0 390 1.00 [ 0.85, 1.00 ] 0.82 [ 0.78, 0.85 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 9. Typhi rapid Tr-02. Reference: BC & PCR. Antibody: IgM.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 9 Typhi rapid Tr-02. Reference: BC % PCR. Antibody: IgM
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Siba 2012 42 68 5 385 0.89 [ 0.77, 0.96 ] 0.85 [ 0.81, 0.88 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 10. Typhidot all tests 1 result per study.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 10 Typhidot all tests 1 result per study
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Begum 2009 13 23 1 18 0.93 [ 0.66, 1.00 ] 0.44 [ 0.28, 0.60 ]
Beig 2010 27 71 3 44 0.90 [ 0.73, 0.98 ] 0.38 [ 0.29, 0.48 ]
Bhutta 1999 39 16 7 35 0.85 [ 0.71, 0.94 ] 0.69 [ 0.54, 0.81 ]
Dong 2007 7 148 6 1571 0.54 [ 0.25, 0.81 ] 0.91 [ 0.90, 0.93 ]
Dutta 2006 41 7 46 33 0.47 [ 0.36, 0.58 ] 0.83 [ 0.67, 0.93 ]
Fadeel 2011 42 5 25 309 0.63 [ 0.50, 0.74 ] 0.98 [ 0.96, 0.99 ]
Gopalakrishnan 2002 41 30 9 64 0.82 [ 0.69, 0.91 ] 0.68 [ 0.58, 0.77 ]
Hosamani 2013 4 24 0 72 1.00 [ 0.40, 1.00 ] 0.75 [ 0.65, 0.83 ]
Islam 2016 18 25 10 54 0.64 [ 0.44, 0.81 ] 0.68 [ 0.57, 0.78 ]
Jesudason 2002 30 6 0 24 1.00 [ 0.88, 1.00 ] 0.80 [ 0.61, 0.92 ]
Jesudason 2006 36 6 3 500 0.92 [ 0.79, 0.98 ] 0.99 [ 0.97, 1.00 ]
Kawano 2007 41 36 34 66 0.55 [ 0.43, 0.66 ] 0.65 [ 0.55, 0.74 ]
Keddy 2011 17 25 10 39 0.63 [ 0.42, 0.81 ] 0.61 [ 0.48, 0.73 ]
Khan 2002 49 26 20 33 0.71 [ 0.59, 0.81 ] 0.56 [ 0.42, 0.69 ]
Khanna 2015 36 5 14 45 0.72 [ 0.58, 0.84 ] 0.90 [ 0.78, 0.97 ]
Khoharo 2011 72 2 2 46 0.97 [ 0.91, 1.00 ] 0.96 [ 0.86, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Mehmood 2015 4 50 11 80 0.27 [ 0.08, 0.55 ] 0.62 [ 0.53, 0.70 ]
Naheed 2008 29 197 14 627 0.67 [ 0.51, 0.81 ] 0.76 [ 0.73, 0.79 ]
Olsen 2004 46 2 12 17 0.79 [ 0.67, 0.89 ] 0.89 [ 0.67, 0.99 ]
Prasad 2015 108 319 3 748 0.97 [ 0.92, 0.99 ] 0.70 [ 0.67, 0.73 ]
Sanjeev 2013 30 7 0 13 1.00 [ 0.88, 1.00 ] 0.65 [ 0.41, 0.85 ]
Siba 2012 22 88 0 390 1.00 [ 0.85, 1.00 ] 0.82 [ 0.78, 0.85 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 11. TUBEX. Reference:BC.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 11 TUBEX. Reference:BC
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Dong 2007 9 89 4 1630 0.69 [ 0.39, 0.91 ] 0.95 [ 0.94, 0.96 ]
Dutta 2006 58 14 45 99 0.56 [ 0.46, 0.66 ] 0.88 [ 0.80, 0.93 ]
Fadeel 2011 50 15 17 299 0.75 [ 0.63, 0.84 ] 0.95 [ 0.92, 0.97 ]
House 2001 56 15 8 48 0.88 [ 0.77, 0.94 ] 0.76 [ 0.64, 0.86 ]
Islam 2016 21 21 7 58 0.75 [ 0.55, 0.89 ] 0.73 [ 0.62, 0.83 ]
Kawano 2007 71 20 4 82 0.95 [ 0.87, 0.99 ] 0.80 [ 0.71, 0.88 ]
Keddy 2011 19 20 9 44 0.68 [ 0.48, 0.84 ] 0.69 [ 0.56, 0.80 ]
Khanna 2015 38 2 12 48 0.76 [ 0.62, 0.87 ] 0.96 [ 0.86, 1.00 ]
Ley 2011 26 12 7 94 0.79 [ 0.61, 0.91 ] 0.89 [ 0.81, 0.94 ]
Naheed 2008 26 166 17 658 0.60 [ 0.44, 0.75 ] 0.80 [ 0.77, 0.83 ]
Olsen 2004 43 1 12 17 0.78 [ 0.65, 0.88 ] 0.94 [ 0.73, 1.00 ]
Rahman 2007 31 37 3 172 0.91 [ 0.76, 0.98 ] 0.82 [ 0.76, 0.87 ]
Siba 2012 17 60 5 418 0.77 [ 0.55, 0.92 ] 0.87 [ 0.84, 0.90 ]
Tarupiwa 2015 12 7 0 112 1.00 [ 0.74, 1.00 ] 0.94 [ 0.88, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 12. TUBEX. Reference: BC & PCR.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 12 TUBEX. Reference: BC % PCR
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Siba 2012 24 53 23 400 0.51 [ 0.36, 0.66 ] 0.88 [ 0.85, 0.91 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 13. TUBEX 1 result per study.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 13 TUBEX 1 result per study
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Dong 2007 9 89 4 1630 0.69 [ 0.39, 0.91 ] 0.95 [ 0.94, 0.96 ]
Dutta 2006 58 14 45 99 0.56 [ 0.46, 0.66 ] 0.88 [ 0.80, 0.93 ]
Fadeel 2011 50 15 17 299 0.75 [ 0.63, 0.84 ] 0.95 [ 0.92, 0.97 ]
House 2001 56 15 8 48 0.88 [ 0.77, 0.94 ] 0.76 [ 0.64, 0.86 ]
Islam 2016 21 21 7 58 0.75 [ 0.55, 0.89 ] 0.73 [ 0.62, 0.83 ]
Kawano 2007 71 20 4 82 0.95 [ 0.87, 0.99 ] 0.80 [ 0.71, 0.88 ]
Keddy 2011 19 20 9 44 0.68 [ 0.48, 0.84 ] 0.69 [ 0.56, 0.80 ]
Khanna 2015 38 2 12 48 0.76 [ 0.62, 0.87 ] 0.96 [ 0.86, 1.00 ]
Ley 2011 26 12 7 94 0.79 [ 0.61, 0.91 ] 0.89 [ 0.81, 0.94 ]
Naheed 2008 26 166 17 658 0.60 [ 0.44, 0.75 ] 0.80 [ 0.77, 0.83 ]
Olsen 2004 43 1 12 17 0.78 [ 0.65, 0.88 ] 0.94 [ 0.73, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Rahman 2007 31 37 3 172 0.91 [ 0.76, 0.98 ] 0.82 [ 0.76, 0.87 ]
Siba 2012 17 60 5 418 0.77 [ 0.55, 0.92 ] 0.87 [ 0.84, 0.90 ]
Tarupiwa 2015 12 7 0 112 1.00 [ 0.74, 1.00 ] 0.94 [ 0.88, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 14. KIT ICT. Reference:BC. Threshold > 1+.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 14 KIT ICT. Reference:BC. Threshold > 1+
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Moore 2014 22 84 2 392 0.92 [ 0.73, 0.99 ] 0.82 [ 0.79, 0.86 ]
Pastoor 2008 32 42 22 113 0.59 [ 0.45, 0.72 ] 0.73 [ 0.65, 0.80 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 15. KIT ICT. Reference: BC & PCR. Threshold > 1+.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 15 KIT ICT. Reference: BC % PCR. Threshold > 1+
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Maude 2015 20 104 14 162 0.59 [ 0.41, 0.75 ] 0.61 [ 0.55, 0.67 ]
Moore 2014 22 84 10 384 0.69 [ 0.50, 0.84 ] 0.82 [ 0.78, 0.85 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 16. KIT latex agglutination. Threshold > 1+.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 16 KIT latex agglutination. Threshold > 1+
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abdoel 2007 31 51 42 301 0.42 [ 0.31, 0.55 ] 0.86 [ 0.81, 0.89 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 17. KIT Dipstick. Threshold > 1+.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 17 KIT Dipstick. Threshold > 1+
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gasem 2002 70 7 21 109 0.77 [ 0.67, 0.85 ] 0.94 [ 0.88, 0.98 ]
Hatta 2002a 73 12 39 378 0.65 [ 0.56, 0.74 ] 0.97 [ 0.95, 0.98 ]
Hatta 2002b 128 57 77 211 0.62 [ 0.55, 0.69 ] 0.79 [ 0.73, 0.83 ]
House 2001 49 3 15 60 0.77 [ 0.64, 0.86 ] 0.95 [ 0.87, 0.99 ]
Ismail 2002 22 7 3 53 0.88 [ 0.69, 0.97 ] 0.88 [ 0.77, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 18. KIT ICT. Threshold > 1+.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 18 KIT ICT. Threshold > 1+
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Maude 2015 20 104 14 162 0.59 [ 0.41, 0.75 ] 0.61 [ 0.55, 0.67 ]
Moore 2014 22 84 2 392 0.92 [ 0.73, 0.99 ] 0.82 [ 0.79, 0.86 ]
Pastoor 2008 32 42 22 113 0.59 [ 0.45, 0.72 ] 0.73 [ 0.65, 0.80 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 19. KIT all tests. Threshold > 1+. One result per study..
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 19 KIT all tests. Threshold > 1+. One result per study.
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abdoel 2007 31 51 42 301 0.42 [ 0.31, 0.55 ] 0.86 [ 0.81, 0.89 ]
Gasem 2002 70 7 21 109 0.77 [ 0.67, 0.85 ] 0.94 [ 0.88, 0.98 ]
Hatta 2002a 73 12 39 378 0.65 [ 0.56, 0.74 ] 0.97 [ 0.95, 0.98 ]
Hatta 2002b 128 57 77 211 0.62 [ 0.55, 0.69 ] 0.79 [ 0.73, 0.83 ]
House 2001 49 3 15 60 0.77 [ 0.64, 0.86 ] 0.95 [ 0.87, 0.99 ]
Ismail 2002 22 7 3 53 0.88 [ 0.69, 0.97 ] 0.88 [ 0.77, 0.95 ]
Maude 2015 20 104 14 162 0.59 [ 0.41, 0.75 ] 0.61 [ 0.55, 0.67 ]
Moore 2014 22 84 2 392 0.92 [ 0.73, 0.99 ] 0.82 [ 0.79, 0.86 ]
Pastoor 2008 32 42 22 113 0.59 [ 0.45, 0.72 ] 0.73 [ 0.65, 0.80 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 20. KIT all tests. Threshold > 2+ studies only.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 20 KIT all tests. Threshold > 2+ studies only
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gasem 2002 52 5 39 111 0.57 [ 0.46, 0.67 ] 0.96 [ 0.90, 0.99 ]
Hatta 2002b 49 34 156 234 0.24 [ 0.18, 0.30 ] 0.87 [ 0.83, 0.91 ]
House 2001 31 1 33 62 0.48 [ 0.36, 0.61 ] 0.98 [ 0.91, 1.00 ]
Maude 2015 14 34 20 232 0.41 [ 0.25, 0.59 ] 0.87 [ 0.83, 0.91 ]
Moore 2014 19 15 5 461 0.79 [ 0.58, 0.93 ] 0.97 [ 0.95, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 21. Enterocheck WB.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 21 Enterocheck WB
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Anagha 2012 17 2 2 62 0.89 [ 0.67, 0.99 ] 0.97 [ 0.89, 1.00 ]
Anusha 2011 47 45 8 350 0.85 [ 0.73, 0.94 ] 0.89 [ 0.85, 0.92 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 22. PanBio.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 22 PanBio
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gopalakrishnan 2002 39 18 11 76 0.78 [ 0.64, 0.88 ] 0.81 [ 0.71, 0.88 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 23. SD Bioline. Antibody: IgG.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 23 SD Bioline. Antibody: IgG
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kawano 2007 41 22 17 70 0.71 [ 0.57, 0.82 ] 0.76 [ 0.66, 0.84 ]
Limpitikul 2014 45 536 90 548 0.33 [ 0.25, 0.42 ] 0.51 [ 0.48, 0.54 ]
Maude 2015 3 6 31 260 0.09 [ 0.02, 0.24 ] 0.98 [ 0.95, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 24. SD Bioline. Antibody: IgM.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 24 SD Bioline. Antibody: IgM
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kawano 2007 40 19 18 73 0.69 [ 0.55, 0.80 ] 0.79 [ 0.70, 0.87 ]
Limpitikul 2014 112 244 87 697 0.56 [ 0.49, 0.63 ] 0.74 [ 0.71, 0.77 ]
Maude 2015 7 7 27 259 0.21 [ 0.09, 0.38 ] 0.97 [ 0.95, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 25. SD Bioline Antibody: IgM and IgG.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 25 SD Bioline Antibody: IgM and IgG
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Maude 2015 8 12 26 254 0.24 [ 0.11, 0.41 ] 0.95 [ 0.92, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 26. Mega Salmonella. Antibody: IgG.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 26 Mega Salmonella. Antibody: IgG
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kawano 2007 72 62 3 40 0.96 [ 0.89, 0.99 ] 0.39 [ 0.30, 0.49 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 27. Mega Salmonella. Antibody: IgM.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 27 Mega Salmonella. Antibody: IgM
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kawano 2007 68 52 7 50 0.91 [ 0.82, 0.96 ] 0.49 [ 0.39, 0.59 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 28. Multi-Test Dip-S-Tick.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 28 Multi-Test Dip-S-Tick
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Olsen 2004 51 9 6 9 0.89 [ 0.78, 0.96 ] 0.50 [ 0.26, 0.74 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 29. Enteroscreen.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 29 Enteroscreen
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Prasad 2015 104 182 14 1221 0.88 [ 0.81, 0.93 ] 0.87 [ 0.85, 0.89 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 30. Onsite Typhoid Combo CTK Biotech.
Review: Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever
Test: 30 Onsite Typhoid Combo CTK Biotech
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Maude 2015 20 70 14 196 0.59 [ 0.41, 0.75 ] 0.74 [ 0.68, 0.79 ]
Tarupiwa 2015 12 7 0 117 1.00 [ 0.74, 1.00 ] 0.94 [ 0.89, 0.98 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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A D D I T I O N A L T A B L E S
Table 1. Summary of all index tests
Index Test
Name
Manufacturer Methods Formats Biological spec-
imen
Thresh-
old for positiv-
ity values
Number of eval-
uations
TUBEX® TF IDL Biotech,
Bromma,
Sweden
Inhibition Bind-
ing Magnetic
Immunoas-
say. Detects IgM
to S. Typhi O9
antigen. Semi-
quantitative col-
orimetric.
Mix buffer/
reagent into plas-
tic well with pa-
tient specimen. 3
minutes for re-
sult
Whole blood,
plasma, or serum
Semi-quantita-
tive colour
change scale (0
to 10) provided
bymanufacturer.
Positive if colour
change scale ≥ 3
14
Typhidot® Malaysian Bio-
Diagnostics Re-
search, Selangor,
Malaysia
Dot-enzyme im-
munoassay. De-
tects IgG and
IgM to 50 kdA
S. Typhi Outer
Membrane Pro-
tein (OMP) anti-
gen.
Mix serum/
whole blood plus
reagent incubat-
ing commer-
cially-prepared
pre-dotted anti-
gen filter paper
strips. 60 min-
utes for result
Whole blood,
plasma, or serum
Quali-
tative: either pos-
itive or negative.
A positive result
is a visible re-
action (IgG or
IgM)of an inten-
sity equal to or
greater than that
of the control re-
action
on the commer-
cially prepared
filter paper
17
Typhidot-M® Malaysian Bio-
Diagnostics Re-
search, Selangor,
Malaysia
Dot-enzyme im-
munoassay. De-
tects IgM to 50
kdA S. Typhi
OMP antigen.
Mix serum/
whole blood plus
reagent incubat-
ing commer-
cially-prepared
pre-dotted anti-
gen filter paper
strips. 60 min-
utes for result
Whole blood,
plasma, or serum
Quali-
tative: either pos-
itive or negative.
Positive
as per Typhidot.
The absence of
any visible spot
indicated a nega-
tive test result
6
TyphiRapid Tr-
02 (Typhidot)
Reszon Diagnos-
tics Interna-
tional, Malaysia
Prototype of Ty-
phidot.
Immunochro-
matography
assay.
Detects IgM to
50 kdA S. Typhi
OMP antigen.
Mix serum/
whole blood plus
buffer/reagent
into a well.
Whole blood,
plasma, or serum
We were unable
to get hold of the
manufacturer
and are awaiting
a response from
the study author
1
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Table 1. Summary of all index tests (Continued)
KIT ICT Test-It
TyphoidT M
LifeAssay Diag-
nos-
tics, Cape Town,
South Africa
Lateral flow im-
munochromato-
graphic (ICT)
assay. Detects
IgM to S. Typhi
lipopolysaccha-
ride (LPS) anti-
gen. Semi-quan-
titative.
Mix serum/
whole blood plus
buffer/
reagent into lat-
eral flow cassette.
Two-site
(test and control)
immunoassay on
a porous nitro-
cellulose mem-
brane. 15 min-
utes for result
Whole blood,
plasma, or serum
Semi-
quantitative re-
sult line intensity
scale (negative to
+4) provided by
manufacturer. A
positive result is
≥ +1
3
KIT Dipstick
Assay
Royal Tropical
Institute (KIT),
Amsterdam
De-
tects IgM to S.
Typhi LPS anti-
gen. Simplified
version of ELISA
technique.
Strip of nitrocel-
lulosemembrane
with immobi-
lized antigen de-
tection band.
Serum
plus reagent in-
cubated on dip-
stick for 3 hours
at room temper-
ature. Dipsticks
rinses with wa-
ter and dried. >3
hours for result
Serum Semi-
quantitative re-
sult line intensity
scale (negative to
+4) provided by
manufacturer. A
positive result is
≥ +1
5
KITDri-DotAs-
say
(latex agglutina-
tion)
Royal Tropical
Institute (KIT),
Amsterdam
Detects IgM to
S. Ty-
phi LPS antigen.
White agglutina-
tion card.
Dot of dried de-
tec-
tion reagent con-
jugated to blue
latex reagent.
Antigen-ac-
tivated latex sta-
bilized by dry-
ing a drop of la-
tex reagent onto
card suspended
in serum. Card
rotated by hand
in near-horizon-
tal position to
further in-
duce agglutina-
tion. 30 seconds
for result
Serum Qualitative: pos-
itive or negative.
Posi-
tive when agglu-
tination was ob-
served within 30
seconds. Nega-
tive when no ag-
glutination was
observed
1
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Table 1. Summary of all index tests (Continued)
SD Bioline
Salmonella typhi
IgG/IgM Fast
Standard
Diagnostics Inc.,
Gyeonggi, Korea
ICT flow
method. Detects
IgM and IgG an-
tibodies to un-
specified S. Ty-
phi antigens.
4 drops
of reagent mixed
well with patient
specimen. Nitro-
cel-
lulose strip sus-
pended intowith
3
sites (IgM, IgG,
and control). 30
minutes for re-
sult
Serum,
plasma, or
whole blood
Qualitative: pos-
itive or negative.
Positive if line
appears in both
control and 1 or
both of IgM or
IgG test zones
3
Enterocheck
WB®
Zephyr Biologi-
cals, Goa, India
ICT
Detects IgM an-
tibodies to S. Ty-
phi LPS antigen.
Two-site (IgM
test, and con-
trol) immunoas-
say cassette on
a porous nitro-
cellulose mem-
brane. 15 min-
utes for result
Whole blood,
plasma, or serum
Qualitative: pos-
itive or negative.
Presence of a line
in
both the test and
control zones in-
dicates a positive
result
2
Enteroscreen ® Zephyr Biologi-
cals, Goa, India
ICT
Detects IgM and
IgG antibodies
to S. Typhi LPS
antigen.
Three-site (IgG,
IgM, and con-
trol) immunoas-
say cassette on
a porous nitro-
cellulose mem-
brane. 15 min-
utes for result
Whole blood,
plasma, or serum
Qualitative: pos-
itive or negative.
Presence of a line
in both the test
(IgG, IgM, or
both) and con-
trol zones indi-
cates a positive
result
1
Multi-test Dip-
S-Tick
PanBio
Inc., Columbia,
Maryland, USA
Tests for five
pathogens, in-
cluding S.Typhi.
Dipstick format
that detects anti-
O, anti-H,anti-
Vi, IgM, or IgG
antibodies
Detailed infor-
mation not avail-
able
Heparinized
whole
blood, serum, or
plasma
Detailed infor-
mation not avail-
able
1
Mega
Salmonella
Mega Diagnos-
tics, Los Angeles,
California, USA
Detect IgG and
IgM antibod-
ies to unspecified
Salmonella anti-
gens. Quantita-
tively de-
tected by ELISA
with peroxidase-
Results read in a
microplate
ELISA reader.
Whole
blood, serum, or
plasma
Detailed infor-
mation not avail-
able
1
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Table 1. Summary of all index tests (Continued)
labelled reagents
OnSite Typhoid
IgG/IgM
Combo
CTK Biotech
Inc., San Diego,
California, USA
Lateral flow im-
munoassay.
Detects IgG and
IgM antibodies
against recombi-
nant O and H S.
Typhi antigens.
Three-site (IgG,
IgM, and con-
trol) immunoas-
say cassette on
a porous nitro-
cellulose mem-
brane. 15 min-
utes for result
Whole
blood, serum, or
plasma
Qualitative: pos-
itive or negative.
Presence of a line
in both the test
(IgG, IgM, or
both) and con-
trol zones indi-
cates a positive
result
2
Abbreviations: immunochromatographic (ICT); immunoglobulin-G (IgG); immunoglobulin-M (IgM); Tropical Institute, Amsterdam
(KIT); lipopolysaccharide (LPS); outer membrane protein (OMP).
A P P E N D I C E S
Appendix 1. Search strategy
Ovid MEDLINE® In-Process & Other Non-Indexed Citations and Ovid MEDLINE®
1 typhoid fever/
2 exp Salmonella enterica/
3 exp paratyphoid fever/
4 “typhoid fever”.mp.
5 “paratyphoid fever”.mp.
6 “enteric fever”.mp.
7 (typhi or paratyphi or “salmonella enterica”).ab. or (typhi or paratyphi or “salmonella enterica”).ti.
8 1 or 2 or 3 or 4 or 5 or 6 or 7
9 “rapid diagnostic test*”.ab. or “rapid diagnostic test*”.ti.
10 RDT*.ab. or RDT*.ti.
11 “serodiagnostic test*”.ab. or “serodiagnostic test*”.ti.
12 (Widal or “DOT enzyme immunoassay” or typhiDOT or TUBEX).ab. or (Widal or “DOT enzyme immunoassay” or typhiDOT
or TUBEX).ti.
13 (“solid-phase” or “DOT blot”).ab. or (“solid-phase” or “DOT blot”).ti.
14 serodiagnosis/
15 immunoblotting/
16 “immunochromatographic lateral flow assay*”.ab. or “immunochromatographic lateral flow assay*”.ti.
17 (typhirapid or “latex agglutination” or “test-it-typhoid” or enterocheck or “SDbioline” or “dip-s-tick” or panbio or “mega salmonella”
or naats or “nucleid acid amplication test*”).ab. or (typhirapid or “latex agglutination” or “test-it-typhoid” or enterocheck or “SD
bioline” or “dip-s-tick” or panbio or “mega salmonella” or naats or “nucleid acid amplication test*”).ti.
18 (“antigen detection” or “antibody detection”).ab. or (“antigen detection” or “antibody detection”).ti.
19 (“blood culture*” or “bone marrow culture*”).ab. or (“blood culture*” or “bone marrow culture*”).ti.
20 Reagent Kits, Diagnostic/
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21 Serologic Tests/
22 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21
23 8 and 22
Embase
1 typhoid fever/
2 exp Salmonella enterica/
3 exp paratyphoid fever/
4 “typhoid fever”.mp.
5 “paratyphoid fever”.mp.
6 “enteric fever”.mp.
7 (typhi or paratyphi or “salmonella enterica”).ab. or (typhi or paratyphi or “salmonella enterica”).ti.
8 1 or 2 or 3 or 4 or 5 or 6 or 7
9 “rapid diagnostic test*”.ab. or “rapid diagnostic test*”.ti.
10 RDT*.ab. or RDT*.ti.
11 “serodiagnostic test*”.ab. or “serodiagnostic test*”.ti.
12 (Widal or “DOT enzyme immunoassay” or typhiDOT or TUBEX).ab. or (Widal or “DOT enzyme immunoassay” or typhiDOT
or TUBEX).ti.
13 antigen detection/
14 antibody detection/
15 blood culture/
16 bone marrow culture/
17 (“solid-phase” or “DOT blot”).ab. or (“solid-phase” or “DOT blot”).ti.
18 serodiagnosis/
19 immunoblotting/
20 “immunochromatographic lateral flow assay*”.ab. or “immunochromatographic lateral flow assay*”.ti.
21 (typhirapid or “latex agglutination” or “test-it-typhoid” or enterocheck or “SDbioline” or “dip-s-tick” or panbio or “mega salmonella”
or naats or “nucleid acid amplication test*”).ab. or (typhirapid or “latex agglutination” or “test-it-typhoid” or enterocheck or “SD
bioline” or “dip-s-tick” or panbio or “mega salmonella” or naats or “nucleid acid amplication test*”).ti.
22 typhoid rapid test/
23 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22
24 8 and 23
Web of ScienceT M Core Collection
Indexes=SCI-EXPANDED
#2 AND #1
# 2 TOPIC: (“rapid diagnostic test*” OR RDT*) OR TOPIC: (“serodiagnostic test*” OR Widal or “DOT enzyme immunoassay” or
typhiDOT or TUBEX) OR TOPIC: (“solid-phase” or “DOT blot” OR serodiagnosis OR immunoblotting) OR TOPIC: (typhirapid
or “latex agglutination” or “test-it-typhoid” or enterocheck or “SD bioline” or “dop-s-tick” or panbio or “mega salmonella” or naats or
“nucleid acid amplication test*”) OR TOPIC: (“antigen detection” or “antibody detection” OR “blood culture*” OR “bone marrow
culture*”)
# 1 TOPIC: (“typhoid fever” OR “paratyphoid fever” OR “enteric fever”) ORTOPIC: (“salmonella typhi” OR “salmonella paratyphi”)
LILACS
Search on : typhoid OR paratyphoid OR salmonella typhi OR salmonella enterica [Words] and “rapid diagnostic test$” OR RDT$
OR widal OR typhidot OR tubex OR serological test$ OR immunoblotting OR DOT [Words]
IndMED, African index Medicus
’typhoid“, ”paratyphoid“, ”enteric fever“, and ”rapid diagnostic test*“, RDT.
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Appendix 2. Data extraction
Study ID First author, year of publication
Clinical features and setting Clinical features: presenting signs and symptoms; index of suspicion for enteric fever (that is, sus-
pected versus unselected febrile); and
recent prior antimicrobial treatment.
Setting: healthcare facility; country; endemicity; and endemic subspecies
Participants Sample size; age; gender; comorbidities; point of recruitment (in-patients/ out-patients); and preg-
nancy
Study design Whether patients enrolled prospectively or retrospectively.
Whether sampling methods were consecutive or random.
If the study enrolledmore than 1 rapid diagnostic test (RDT), how were tests allocated to individuals
or did individuals receive all the tests?
Were RDTs used on suspected typhoid/paratyphoid cases or unselected febrile patients?
Target condition Typhoid fever or paratyphoid fever, or both
Reference standard Which reference standard was used (bone marrow/blood culture/PCR/combination)?
Who performed the reference standard test(s)?
Where was the test performed?
How many repeats were used?
Number of observers/operators.
Methods of inter-observer discrepancy resolution.
Has the laboratory received quality accreditation by an external agency?
Index tests Salmonella enterica serovars designed to detect Typhi (typhoid), Paratyphi A (paratyphoid), or both
Commercial name.
Blood or urine.
If blood RDT, capillary or venous blood.
Antigen or antibody detection.
If antibody detection, subclass detected (that is, IgG/IgM).
Format.
Transport and storage conditions.
Details of test operators, including any special training provided
Where was the test performed?
Number of observers/operators and methods of inter-observer discrepancy resolution
Threshold, that is, what constituted a positive result?
Data Numbers of true positives, false positives, true negative, and false negatives
Notes Source(s) of funding
Abbreviations: Rapid diagnostic test (RDT); Immunoglobulin-G (IgG), Immunoglobulin-M (IgM); Polymerase chain reaction (PCR).
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Appendix 3. Assessment of methodological quality
Quality indicator Notes
1. Patient selection 1. Patient selection
Was a consecutive or random sample of patients enrolled? Yes: if the study recruited a consecutive or random sample of
eligible patients
No: if the study selected patients by convenience
Unclear: if the study did not report the method of patient selec-
tion, or this was not clearly reported
Was a case control design avoided? Yes: if the study recruited unselected febrile patients
No: if the study recruited confirmed or suspected cases of enteric
fever, or both as a case group
Unclear: for all other scenarios or if this was not clearly reported
Did the study avoid inappropriate exclusions? Yes: if there were no participants excluded from the analysis, or if
exclusions were adequately described
No: if there were unexplained exclusion of participants
Unclear: if insufficient information was given to assess whether
any participants were excluded from the analysis
Could the selection of patients introduced bias? Low risk: inclusion and exclusion criteria clearly described, for
example, patients with fever, patients suspected to have enteric
fever, or both
High risk: inclusion and exclusion criteria not included
Unclear risk: If selection criteria were partially reported
Are there concerns that the included patients and setting do not
match the review question?
Low concern: patients with fever and recruited from an area of
high or medium endemicity for enteric fever as defined by Crump
2004
High concern: patients without fever or recruited from an area of
low endemicity for enteric fever (Crump 2004)
Unclear concern: if the location or clinical characteristics of par-
ticipants were not adequately described
2. Index test 2. Index test
Were the index test results interpreted without knowledge of the
results of the reference standard?
Yes: person undertaking the index test did not know the results
of the reference tests, or if the tests were carried out in different
places
No: if the same person performed both tests, or the results of the
reference tests were known to the person undertaking the index
tests
Unclear: if insufficient information provided
If a threshold was used, was it pre-specified? Yes: if the threshold’s pre-specified by the respective manufacturers
were described and followed
No: if the manufacturer’s thresholds were described but not fol-
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(Continued)
lowed
Unclear: if this is not clearly described or there were no thresholds
for the evaluated RDT
Could the conduct or interpretation of the index test have intro-
duced bias?
Low risk: if the index test was utilized according tomanufacturers’
instructions
High risk: if the use of index tests(s) deviated frommanufacturers’
instructions
Unclear risk: if insufficient information provided
Are there concerns that the index test, its conduct, or interpreta-
tion differ from the review question?
Low concern: if the index test was used to diagnose enteric fever in
symptomatic patients from areas of high or medium enteric fever
endemicity (Crump 2004)
High concern: if the index test was used to diagnose enteric fever
in patients from areas of low endemicity for enteric fever (Crump
2004), or those who are asymptomatic
Unclear concern: if the location or clinical characteristics of par-
ticipants were not described
3. Reference standard 3. Reference standar
Is the reference standard likely to correctly identify the target con-
dition?
Yes: if bone marrow and blood culture (Grade 1 Reference stan-
dard) are performed at an externally accredited laboratory and
adequate blood/marrow volumes were taken (Wain 1998; Wain
2001)
No: If inadequate blood/marrow volumes were taken (Wain 1998;
Wain 2001)
Unclear: if blood culture alone (Grade 2 Reference standard) is
performed, or if external quality assurance accreditation of the
relevant laboratory or blood/marrow volumes were not described
Were the reference standard results interpretedwithout knowledge
of the results of the index tests?
Yes: person undertaking the reference test did not know the results
of the index tests, or if the tests were carried out in different places
No: if the same person performed both tests, or the results of the
index tests were known to the person undertaking the reference
tests
Unclear: if insufficient information provided
Could the reference standard, its conduct, or its interpretation
have introduced bias?
Low risk: if the reference standard results and index tests were
analysed separately
High risk: if the reference standard results and index tests results
were analysed together
Unclear risk: if insufficient information was provided
Are there concerns that the target condition as defined by the
reference standard does not match the question?
We will judge this to be ’low risk’ for all studies that use isolation
of Salmonella Typhi, or Paratyphi A, or both from blood,bone
marrow, or both
4. Flow and timing 4. Flow and timing
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(Continued)
Was there an appropriate interval between index test and reference
standard?
Yes: if the index test and reference standard(s) were collected on
the same patients at the same time or within 24 hours of each
other
No: if the time period between index test and reference standard
(s) collection was > 24 hours
Unclear: if the time period between index test and reference stan-
dard collection was not described
Did all patients receive the same reference standard? Yes: if the same reference test(s) was/were used in all participants
No: if different reference test(s) was/were used depending on index
test results
Unclear: if insufficient information was provided
Were all patients included in the analysis? Yes: if the number of participants in the two-by-two tablematched
the number of participants recruited into the study or if sufficient
explanation was provided for any discrepancy
No: number of participants in the two-by-two table did not match
the number of participants recruited into the study and insuffi-
cient explanation was provided for any discrepancy
Unclear: if insufficient informationwas given topermit judgement
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We amended the reference test definition when it became apparent that some studies had used a PCR test to detect Salmonella Typhi
or Salmonella Paratyphi A DNA in blood samples. We included peripheral blood PCR in addition to peripheral blood culture as a
Grade 2 reference standard. In the studies that used a blood PCR in addition to blood culture, a positive blood culture or blood PCR
represented a positive reference test.
During the interval between protocol and full review publication, a modified tool assessment of methodological quality was ratified
and released (QUADAS-2). We used this newer tool for the full review instead of QUADAS-1 as originally intended in the protocol
(Appendix 3).
The major differences between the protocol and the review relate to the intended statistical analysis. Some of the studies of the Test-
it Typhoid test and its KIT prototypes used two test thresholds. We were able to use bivariate analysis to focus on test operating
points instead of hierarchical summary receiver operating characteristic (HSROC) analysis. Typhidot and TUBEX tests results did not
use different test thresholds. A number of the planned statistical analyses of subgroups were underpowered due to the low number
of available studies. The main subgroup analysis performed was by test manufacturer (Typhidot/Typhidot-M, TUBEX and Test-it
Typhoid and KIT prototype RDTs) as therewere sufficient available studies to potentially allow robust comparisons.We did not perform
the following planned subanalyses: Salmonella enterica serovars (Typhi, Paratyphi A, or both); reference standard test applied (bone
marrow and blood culture [Grade 1] versus blood culture alone [Grade 2]); study design (case control, prospective cohort, randomized
controlled trial, paired comparative trial); test population (clinically-suspected enteric fever versus unselected febrile patients); and
index test biological sample type (blood versus urine). Where possible we have replaced these subanalyses with graphical presentation
of subgroups in SROC plots.
For the Typhidot test and its variants we decided to extract the IgM data alone from each study. Typhidot detects both IgG and
IgM antibodies, while Typhidot-M detects IgM antibodies only. A detectable IgG result may indicate current or recent acute but also
previous infection whereas IgM indicates current or recent acute infection. In order to compare the data of Typhidot with the data of
Typhidot-M, if the IgM data was not recorded separately from the IgG data, we excluded the results.
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